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ABSTRCT
Cytotoxic Lymphocytes in Viral Hepatitis
(April 1987)
Kim W. McIntyre, B. A., University of Rhode Island
Ph. D., University of Massachusetts Medical School
Directed by: Raymond M. Welsh
The immunological mechanisms involved in virus-induced
hepatitis were examined by measuring the cytotoxic capabilities
and the morphological and antigenic phenotypes of leukocytes
isolated from the livers of virus-infected mice. Large granular
lymphocytes (LGL) of both natural killer (NK) cell and cytotoxic
T lymphocyte (CTL) phenoytpes accumulated in livers of mice
infected with lymphocytic choriomeningitis virus (LCMV) of either
the nonhepatotropic Armstrong strain (LCMV-AR) or the hepato-
tropic WE strain (LCMV-WE). NK cell activity and L L number
increased 3- to 4-fold between days 1 and 5 postinfection 
(p. i.
These LGL were characterized as NK cells on the basis of cell
surface antigens, kinetics of appearance, target cell range, and
morphology. By day 7 p. i., virus-specific, H-Z-restricted, Thy-
, Lyt-Z+ CTL activity was present in the liver, and its
appearance correlated with a second wave of LGL accumulation.
Total CTL activity, leukocyte numbers, and CTL/LGL numbers were
at least 5-fold higher in the livers of LCMV-WE-infected mice
than in the livers of LCMV-AR-infected mice. Mice infected with
the cytopathic viruses, mouse hepatitis virus and murine
cytomegalovirus, experienced greater increases in NK/LGL by day 3
p. i. than did mice either infected with LCMV or inj ected with
poly I:C. The early and late accumulations of LGL in the virus-
infected liver were associated with the appearance of two waves
of LGL with blast cell morphology expressing the phenotypes of NK
cells and CTL, respectively. Thus, the organ-associated
accumulation, blastogenesis, and in situ proliferation of
cytotoxic LGL provide a means for the localization and site-
specific augmentation of a host' . cell-mediated antiviral
defenses.
The mechanism of inhibition of virus synthesis in vivo by
immune splenocytes containing virus-specific CTL was examined in
mice dually infected with two different viruses and then
adoptively immunized with spleen cells immune to one of the two
viruses. Only the titer of the virus to which the splenocytes
were immune was reduced in titer, and no nonspecific antiviral
effect was seen on the titer of the ' bystander ' heterologous
virus. These data are consistent with an in vivo mechanism of
CTL-mediated antiviral resistance involving direct cytotoxicity
rather than release and dissemination of antigen-nonspecific
antiviral factors, . such as interferon, following recognition of
appropriate viral antigen.
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CHATER I
INTRODUCTION
Cytotoxic lymphocytes are intimately involved in the
regulation and eradication of viral infections in mamalian
hosts. The particular cytotoxic effector cells responsible for
these roles and the extent of their influence may vary among
different infections. The reasons for this variation may include
such factors as viral cytopathogenicity, route of entry of the
virus, tissue tropism( s) of the virus, previous exposure to the
infecting agent, as well as the imunological competence, genetic
background, and age of the host.
This dissertation examines the involvement of two types of
cytotoxic lymhocyte, the natural killer (NK) cell and the
cytotoxic T lymhocyte (CTL), in viral infections which cause
hepatic disease. The mechanism whereby virus-imune CTL mediate
antiviral protection in vivo is probed. The types of cytotoxic
effector cells induced to accumlate in the liver following
infection with a variety agents of viral hepatitis are
characterized phenotypically, functionally, and morphologically.
These new data, when correlated with current knowledge of the
relative importance of particular cytotoxic lymphocytes in
certain viral infections, broaden understanding of the mechanisms
of antiviral resistance and imunopathology in viral disease.
A. Cytotoxic T lymhocytes (CTL)
1. The early evidence. Experimental evidence for a direct
role of the imne system in providing protection from viral
infection came from early studies in mice infected with
lymphocytic choriomeningitis virus (LCM), a natural pathogen of
mice (Traub, 1936). The relatively non-specific
imnosuppressive effects of x-irradiation or of cytoreductive
drgs prevented lethal meningitis in adult mice following
intracerebral (i. c . ) inoculation of virus (Hotchin and Weigand,
1961; Hannover Larsen, 1969; Gilden et al., 1972a). Similar
results were achieved following neonatal thymectomy (Rowe et al.,
1963) or in vivo administration of anti-thymocyte seru (Hirsch
et al., 1967), imlying involvement of a thymus-derived (T) cell.
While mice treated in this fashion often did not die during
subsequent viral challenge, they generally failed to clear the
virus and became chronically, or persistently, infected. It was
thus apparent that the virus itself was not directly responsible
for death of normal mice, but rather a thymus-dependent component
(T lymhocyte?) of the host was responsible for the marked
accumlations of inflamatory cells in the central nervous system
and the ensuing destruction of neural tissue (Hannover Larsen,
1969; Rowe et al., 1963; Hirsch et al., 1967).
These methods of imunosuppression did not successfully
protect mice from all viral infections. Infections caused by
vesicular stomatitis virus (Rowe et al., 1963), ectromelia virus
(Blanden, 1970), murine cytomegalovirus (Brody and Craighead,
1974), and vaccinia virus (Hirsch et al., 1968; Worthington,
1973) were decidedly worsened by imnosuppressive treatment, and
mortality was usually increased. Thus, in certain instances the
imne system seemed to be the cause of disease, while in others
it was the cure. Realistic hypotheses explaining this paradox
were formlated when it was found that virus-imune leukocytes
could preferentially interact with virus-infected target cells in
vitro leading to the destruction of the target cells or to
inhibition of virus spread (Speel et al., 1968; Lundstedt, 1969;
Oldstone et al., 1969; Oldstone and Dixon, 1970; Ennis, 1973;
Zinkernagel and Althage, 1977). This effect was variably
attributable either to release of cytotoxic factor(s) into the
culture supernatant (Speel et al., 1968; Oldstone and Dixon,
1970) or to direct cell-to-cell contact (Oldstone and Dixon,
1970; Ennis, 1973). The development of a quantitative in vitro
assay (Brunner et al., 1968) for the activity of killer
lymphocytes simlified measurements of this phenomenon. From
these findings it was surmised that imune lymphocytes might
reduce viral titers in vivo by killing virus-infected cells
before progeny viruses were produced. Alternatively, if many
cells in a vital organ (such as the brain) were infected, their
imne cell-mediated destruction could produce severe pathology
or death.
2. H-2 restriction. Demonstrations of cytotoxic T lymphocytes
generated during the course of viral infection were soon to
follow for a variety of viruses including ectromelia virus
(Gardner et al., 1974a; Gardner et al., 1974b), LCM (Marker and
Volkert, 1973), and Sindbis virus (McFarland, 1974). In 1974, a
major advance in imnology was made by the demonstration that
LCM-specific CTL-mediated lysis of LCM-infected target cells
was restricted by antigens of the major histocompatibility
complex (MHC), H-2, of the mouse (Zinkernagel and Doherty, 1974).
That is, the killer cell had to be generated ina mouse bearing
H-2 antigens common with those expressed on the target cell for
lysis to occur. The genes coding for these antigens were mapped
to the K andD regions (class I genes) of the H-2 complex
(Blanden et al., 1975; Zinkernagel and Doherty, 1975).
Expression of the class I gene proteins on the virus-infected
target cell surface was requisite for a lytic interaction
(Zinkernagel and Oldstone, 1976). Increased levels of class I
antigen expression, induced by exposure of virus-infected targets
to interferon (IFN), enhanced target cell sensitivity to virus-
specific CTL-mediated lysis (Bukowski et al., 1985a). This
requirement for H-2-restriction was extended to vaccinia virus
(Koszinowski and Ertl, 1975), influenza virus (Ennis et al.,
1977), Bebaru virus (Mullbacher and Blanden, 1978), and murine
cytomegalovirus (Quinnan et al., 1978). CUriously, some strains
of mice failed to generate detectable virus-specific CTL activity
when infected with certain viruses, and this "defect" in imune
responsiveness often mapped to the class I regions of H-2
(Mullbacher and Blanden, 1978; Rosenthal and Zinkernagel, 1981).
3. Antiviral activity and imnopathology. Volkert (1962)
provided some of the earliest evidence that transfer of
lymhocytes (adoptive imnization) from virus-imne mice could
reduce viral titers in infected recipient mice. Later studies
showed that imne T cells were necessary for this antiviral
effect (Blanden, 1971) and that T lymhocytes were also important
mediators of imunopathology (Cole et al., 1972). By adoptive
imnization, in vivo antiviral effects of imune T cells were
shown for diseases as diverse as viral meningitis (Gilden et al.,
1972b; Hoffsten et al., 1977) and viral pneumonia (Yap and Ada,
1978a; Yap et al., 1979). The in vivo antiviral (Zi ernagel and
Welsh, 1976; Yap et al., 1978) and imunopathological (Doherty et
al., 1976) activities of transferred imune T cells were shown to
be class I antigen-resticted, analogous to the MHC-restriction
seen in vitro. Furthermore, a virus-specific, H-2-restricted CTL
clone adoptively imunized virus-infected mice (Byrne and
Oldstone, 1984). Mutant nude mice (Flanagan, 1966), which lack a
thymus (Pantelouris, 1968) and, consequently, thymus-dependent T
lymphocytes, were unable to mount a CTL' response and were very
sensitive to murine cytomegalovirus (MCM) infection (starr and
Allison, 1977). Most investigators concluded that antiviral
protection and/or imunopathology were likely to be mediated
predominantly by imune T cells of the CTL subset, although
discrepancies have been noted (Varho et al., 1981; Thomsen et
al., 1983; Thomsen and Volkert, 1983; Marker et al., 1985; pfau
et al., 1985).
Virus-specific CTL also accumulated at sites of viral
replication in the host during infection. CTL could be found in
cerebrospinal fluid during poxvirus (Hapel and Gardner, 1974;
Morishima and Hayashi, 1978) and LCM (Zinkernagel and Doherty,
1973) meningitis, in the peritoneal cavity during viral
peritonitis (Pang et al., 1976), and in the lungs during MCM
(Reddehase et al., 1985), influenza virus (Yap and Ada, 1978b;
Ennis et al., 1978), and respiratory syncytial virus (Taylor et
al., 1985) pneumonia. That virus-specific CTL displayed the same
MHC class I-restricted patterns of activity in vitro and in vivo,
and that they accumulated at sites of viral repication, further
strengthened the arguent that it was in fact the CTL that were
responsible for mediating antiviral effects in vivo.
B. Natural killer cells
1. Discover At about the time Zinkernagel and Doherty
( 1974) were unraveling the imortance of H-2-restriction in CTL-
target cell interactions, other investigators were witnessing a
phenomenon of H-2- restricted in vitro cytolysis. This killing
was reportedly mediated by a Thy-negative (non-T) cell which was
present in normal mice (Lamon et al., 1973) and in tumor-
inoculated mice (Herberman et al., 1973). These effector cells.
were called "natural" killer (NK) cells by Kiessling et al
(1975a), since they showed spontaneous cytotoxicity when obtained
from unimunized, naive mice. Because they showed a tendency to
preferentially lyse certain virus-induced tumor cells (Lamon et
al., 1973; Herberman et al., 1973; Kiessling et al., 1975b), it
was postulated that they might provide a first line of defense
against tumors arising in vivo. High levels of NK cell activity
were found in the spleens of mice, but the activity was low or
absent in lymh nodes, bone marrow and thymus (Kiessling et al.,
1975a) . NK cell activity showed age-dependent variations, being
low in neonatal mice, increasing to peak levels between 3-7 weeks
of age, and gradually declining in later months (Kiessling et
al., 1975a). An intact and functional bone marrow
microenvironment was necessary for the development and
maintenance of NK cell activity (Haller and Wigzell, 1977; Haller
et al., 1977; Kumar et al., 1979). The presence of NK cells in
the spleens of nude mice, and the absence (Kiessling et al.,
1975a) or low levels (Herberman et al., 1978) of Thy antigen on
NK cells from normal mice, suggested that this effector
population was truly different from the classical CTL.
2. The NK cell-virus connection. Evidence of non-specific
cytotoxic activity, often seen during the early course of viral
infections, was reported by other investigators (Blanden and
Gardner, 1976; Rodda and White, 1976; Wong et al., 1977;
MacFarlan et al., 1977; Herberman et al., 1977). Because the in
vitro pattern of lytic activity resemled that reported by
Kiessling et al (1975b) and because the activity was augmented
early during viral infection, it was proposed that NK cells might
provide an imunologically nonspecific first line of defense
against viruses (Welsh and Zinkernagel, 1977; Welsh, 1978b; Welsh
et a!., 197
Augmented NK cell activity during viral infection coincided
with the production of interferon (IFN) and preceded the peak of
virus-specific CTL activity (Welsh and Zinkernagel, 1977; Welsh,
1978a) . This augmented, or "activated" , NK cell activity was
reflected in an increased ability to lyse targets normlly
resistant to resting " endogenous" NK cells (Welsh and
Zinkernagel, 1977; Welsh et al., 1979). Injections of IFN or
IFN-inducers resulted in NK cell activation (Welsh, 1978a;
Gidlund et al., 1978; Djeu et al., 1979a; Djeu et al., 1979b),
and this activation was blocked by anti-IFN antibody administered
in vivo (Gidlund et al., 1978). IFN augmented NK cell activity
by recruit ng non-lytic pre-NK cells and enhancing the kinetics
of NK cell lysis (Silva et al., 1980). IFN-inducers or IFN alone
also resulted in the blastogenesis and proliferation of spleen NK
cells leading to an increase in their numer in vivo (Kiessling
et al., 1980; Biron and Welsh, 1982; Biron et al., 1983; Biron et
a!., 1984). Together , the increased NK cell numers and
increased lytic activity on a per cell basis account for the
overall NK cell activation witnessed during viral infection or
IFN exposure.
3. NK cell-mediated antiviral effects. with the
demonstrations of NK cell activation during viral infection, a
search began for an antiviral role for these cytolytic effector
cells and a numer of correlations between NK cell activity and
antiviral resistance were to follow. Mice with genetically high
NK cell activity showed increased resistance to herpes simplex
virus (HSVi Lopez, 1981) and MCM (Bancroft et al., 1981)
compared to mice with low NK cell activity. Mice homozygous for
the beige mutation, which confers low levels of NK cell activity
(Roder and Duwe, 1979), were more sensitive than their NK cell-
normal heterozygous littermates to MCM infection (Shellam et
al., 1981). Neonatal mice were susceptible to mouse hepatitis
virus (MHV) infection, but developed a natural resistance by 3
weeks of age (Tardieu et al., 1980), coinciding with their age-
dependent acquisition of NK cell activity (Kiessling et al.,
1975b) . Treatments known to augment NK cell activity provided
enhanced resistance to subsequent MCM (Ebihara and Minamishima,
1984) and influenza virus challenge (Spencer et al., 1977).
These data were highly suggestive of a role for NK cells in
mediating antiviral activity. However, the close relationship
between IFN-mediated NK cell activation and IFN s potential
direct antiviral effects in the early course of viral infections
made it difficult to assign a relative importance to each of
these purported resistance mechanisms. Furthermore, these
correlations did not hold for all viruses. LCM (Welsh and
Kiessling, 1980; Allan and Doherty, 1986) and Sindbis virus
(Hirsch, 1981) infections were not different in mice homozygous
or heterozygous for the beige mutation. Thus, NK cell-mediated
resistance did not appear to apply to all viral infections.
The most definitive evidence that NK cells directly provide
resistance to at least certain viral infections has come from the
work of Bukowski et al (1983b; 1984; 1985). With the development
of an antibody reagent directed against the neutral
glycosphingolipid ganglio-tetraosylceramide (asialo GM1) present
in high concentrationsonNK cells, it became possible to
selectively deplete NK cell activity in vitro (Kasai et al.,
1980) and in vivo (Habu et al., 1981). Pretreatment with anti-
asialo GMI rendered mice more susceptible (i. e., higher organ
virus titers and virus-induced tissue pathology) to infection
with MH, MCM, and vaccinia virus, but not to LCM (Bukowski et
al., 1983b; Bukowski et al., 1984). This increased
susceptibili ty was not due to inhibition of the IFN response to
infection as anti-asialo GM1-treated mice had higher IFN titers
than infected controls (Bukowski et al., 1983b; Bukowski et al.,
1984) . Adoptive transfer of NK cell-containing normal adult
lymhocytes, or of cloned NK cells, into NK cell-deficient
neonatal mice protected them against an otherwise lethal
challenge of MCM (Bukowski et al., 1985). Any treatment which
depleted NK cell. activity from the transferred donor population
abrogated the cells ' in vivo anti-MCM protective effect
(Bukowski et al., 1985). These experiments provided the first
direct demonstration of the antiviral activity of NK cells in
vivo.
4. Mechanism of NK cell-mediated antiviral action. IFN
generated in vivo during early viral infection activates NK
cells, making them capable of lysing almost any normal, tumor, or
virus-infected target cell (Welsh et al., 1979). If one accepts
the proposal that NK cells may inhibit early viral replication by
lysing virus-infected target cells in vivo (Welsh et al., 1979),
how is wide-spread destruction of surrounding uninfected tissue
prevented? Several studies have reported that NK cells may
preferentially lyse virus-infected cells compared to uninfected
cells (Quinnan and Manischewitz, 1979; Welsh and Hallenbeck,
1980; Piontek et al., 1980; Arerding et al., 1981). This
phenomenon was usually seen using endogenous control spleen
effector cells in long in vitro assays, conditions which may
allow for activation of NK cells by IFN-dependent (Trinchieri and
Santoli, 1978) or IFN-independent (Lee and Keller 1982)
mechanisms. In short assays with activated NK cells, such
preferential lysis of virus-infected target cells was not the
rule (Welsh and Hallenbeck, 1980).
In addition to activating NK cells to kill more efficiently,
IFN also has the interesting property of protecting target cells
from activated NK cell-mediated lysis (Trinchieri and Santoli,
1978, Welsh et al., 1981; Trinchieri et al., 1981). Since IFN
protection requires target cell protein and-RNA synthesis (Welsh
et al., 1981), infection of that cell by a virus which usurps
host cell metabolism would render it insensitive to IFN
protection. Cytopathic viruses, like MCM and MH, tend to shut
down host cell metabolism, while relatively non-cytopathic
viruses like LCM do not. Variation in susceptibility to IFN
protection of virus-infected cells may be crucial in determining
the extent of NK cell-mediated influence in controlling a
particular infection. Thus, an in vivo scenario during viral
infection may be hypothesized: 1) virus invades the host, begins
replication, resulting in local and systemic IFN production;
IFN augments NK cell activity through activation and
proliferation; 3) IFN protects uninfected cells and cells
infected with non-cytopathic viruses from NK cell lysis; 4) IFN
fails to protect cells infected with cytopathic viruses from
activated NK cell lysis which can then abort viral replication . in
those cells. This proposal, and convincing data directly
supporting it, have been presented (Trinchieri and Santoli, 1978;
Bukowski and Welsh, 1985b).
To exert a direct antiviral effect by cytolysis, NK cells
must accumulate locally at a site of viral infection. Several
studies have shown NK, or NK-like, cells in cerebrospinal fluid
during meningitis of various viral etiologies (Doherty and
Korngold, 1983; Moench and Griffin, 1984; Allan and Doherty,
1986) . Augmented NK cell activity also developed in the lungs
during influenza virus pneumonia (Leung and Ada, 1981; Mann et
al., 1985) and in the peritoneal cavity following infection with
several different viruses by the intraperitoneal (i.p. ), but not
the intravenous (i. v . ), route (Natuk and Welsh, 1987; Natuk et
al., 1987). Both NK cells and CTL thus appear to accumulate at
sites of virus infection, a finding readily anticipated from the
hypothesis that they mediate antiviral activity by direct
cytolytic mechanisms.
C. Large granular lymhocytes (LGL)
Timonen et ale (1979), working with human peripheral blood
lymhocytes, drew the first correlations between NK cell activity
and the presence of cells morphologically described as large
granular lymphocytes (LGL). These LGL displayed relatively
abundant cytoplasm, prominent azurophilic cytoplasmic granules,
and indented reniform nuclei. This relationship between
morphology and function was soon extended to murine NK cells
(Luini et al., 1981; Kumagai et al., 1982; Itoh et al., 1982).
When granules were purified from NK cell LGL tumors of the rat,
they were directly lytic for target cells, implying involvement
of the granules in the NK cell lytic process (Millard et al.,
1984) .
Investigations of T lymphocytes from various sources also
revealed the presence of granules in the cytoplasm of cells of
this lineage (Schrader et al., 1983; Podack and Konigsberg,
1984) . Furthermore, mouse T lymhocytes maintained in culture
often showed an NK cell-like pattern of cytotoxicity, and this
was reflected by their LGL morphology (Brooks et al., 1982;
Shortman et al., 1983). The granules isolated from in vitro
maintained CTL lines were able to mediate target cell lysis
(Podack and Konigsberg, 1984; Young et aI, 1986b). The lysis
appeared to be due to the formation of channels in the plasma
memrane of target cells by the polymerization of a protein of
the granules, forming structures analogous to the pores formed by
components of the complement cascade (Henkart et al., 1985;
podack, 1986; Young et al., 1986a). Evidence was presented that
both NK cells and CTL utilize similar pathways in their lytic
interactions with target cells (Hiserodt, 1985). The question
arose, however, as to whether the granules found in LGL of T cell
lineage maintained in vitro were a culture-induced artifact, or
were they a true representation of the lytic machinery of normal
This uncertainty was recently resolved when freshly
isolated, in vivo-generated, virus-specific CTL were shown to
also exhibit the classical LGL form (Biron and Welsh, 1986; Biron
et al., 1986). Although these C /LGL were morphologically
indistinguishable from NK/LGL, the two cell types could be
clearly differentiated on the basis of specific cell surface
antigen expres ion and of the kinetics of their appearance
following viral infection (Biron and Welsh, 1986; Biron et al.,
1986) . Thus, the proposal that the lytic mechanisms of NK cells
and CTL are quite similar (Hiserodt, 1985) is supported by the
finding of a common morphology (LGL) and a common function
(cytolysis) for these two effector lymhocytes.
D. Cell-mediated imnity in viral hepatitis
One of the most clinically significant and extensively
studied causes of hum viral hepatitis is hepatitis B virus
( HBV) . HBV is generally considered to be a relatively non-
cytopathic virus. Liver pathology in HBV infection appears to be
imne system-mediated with cell-mediated imnity proposed to be
the major cause of hepatocyte death (Dudley et al., 1972). HBV-
infected patients on imunosuppressive chemotherapy show little
clinical evidence of hepatitis until the cessation of treatment
when an acute bout of hepatitis may ensue (Galbraith et al.,
1975) . Similarly, renal dialysis patients with imune
dysfunction often show a limited and delayed necrosis of
hepatocytes (Nordenfelt et al., 1970). Specific antibody does
not appear to significantly, contribute to the pathology of acute
disease since agamaglobulinemic individuals experience classical
HBV infections (Good and Page, 1960; Gelfand, 1974). Rather,
antibody may block cell-mediated imne responses in vivo
resulting in delayed viral clearance and increased likelihood of
developing persistent infection (Mon elli and Eddleston, 1984).
A much higher percentage of B lymphocytes in liver biopsy
specimens from patients with a chronic persistent hepatitis, as
compared to biopsies from patients with acute hepatitis, supports
this hypothesis (Husby et al., 1975; Miller et al., 1977).
Peripheral blood lymphocytes (PBL) from HBV-irne patients
showed a selective NK cell-like cytotoxicity for HBV-infected
hepatoma cells (Chin et al., 1983) and autologous hepatocytes
(Eddelston et al., 1982). Virus-specific CTL, demonstrated in
PBL from HBV-convalescing patients, showed preferential
recognition of HBV core antigen on the surface of infected
hepatocytes (Eddelston et al., 1982; Mondelli et al., 1982).
However, chronic HBV patients undergoing prolonged IFN therapy
often experience an acute exacerbation of hepatitis w
increasing seru transaminases while concomitantly losin
demonstrable cytotoxic cells from the blood (Dr. A. L. W . F .
Eddelston, personal commnication). Thus, in studies using PBL,
the data give little insight into the in situ relationship
between cytotoxic effector cells and virus-infected hepatocytes.
Histological analysis of human liver biopsies has
demonstrated the presence of lymhocytes expressing the 
antigen of cytotoxic/suppressor cells. ' These T8+ lymphocytes
predominated (approx. 75%) over other T lymhocyte subsets in
areas of hepatocyte necrosis (Montano et al., 1983; Egg ink 
al., 1984; Pape et al., 1983). The proportion of T8+ lymphocytes
in PBL of the same patients was considerably lower (30%),
suggesting a selective accumlation of T8+ lymphocytes in the
infected liver. This again raises the question of the validity
of correlating imnological events in the liver with PBL
function and phenotype (Pape et al., 1983).
Lymhocytes expressing NK cell antigens (Leu-7, HNK-1)
occassionally comprised up to 25% of lymphocytes associated with
areas of hepatic necrosis in acute HBV hepatitis (Eggink et al.,
1984) and acute cytomegalovirus hepatitis (Pape et al., 1983).
Furthermore, at the ultrastructural level, lymphocytes with
reniform nuclei (Kawanishi, 1977) and cytoplasmic granules
(Karasawa and Shikata, 1977) were found in intimate cell-surface
contact with necrotic hepatocytes, imlying a lymphocyte (LGL?)-
mediated, contact-dependent cytotoxicity. Unfortunately, these
morphological descriptions provide only a static representation
of what must be a highly dynamic process, and one can only infer
functional activities of the lymphocytes from their
imnophenotypes. Recently, cloned lines of interleukin 2 (IL-
2)-dependent CTL were derived from liver biopsies of HBV-infected
patients (Hoffmann et al., 1986). Whether these in vitro CTL
cell lines accurately reflect the in vivo function and
specificity of lymphocytes that accumlate in the liver during
viral hepatitis remains to be determined.
Numerous other viruses are capable of causing hepatitis in
humans. However, the evidence that cellular imnity plays a
significant role in mediating antiviral resistance or causing
imunopathology in any of these diseases is less compelling.
Elevated cytotoxicity by PBL for autologous hepatocytes was shown
in patients with non-A, non-B (NAN) hepatitis (Poralla et al.,
1984; Mondelli et al., 1986). Both T cell enriched and T cell-
depleted populations were cytotoxic in those studies, although
some degree of antigen- and/or MHC-restricted specificity
appeared operative in one case (Mondelli et al., 1986).
Unfortunately, the regions of hepatocellular necrosis in the NAN
hepatitis liver did not coincide with the areas of inflamatory
cell infiltration, leading to the speculation that pathology was
not imune cell-mediated but rather due to direct viral
cytopathic effects (Dienes et al., 1982).
Hepatitis A virus (HAV)-infected cells were more readily
lysed by normal, non-imune PBL than were uninfected cells
(Kurane et al., 1986). This I preferential lysis I appeared to be
due mainly to the in vitro activation of NK cells by IFN
generated in the culture wells during the relatively long assay
per iod. Whether a similar mechanism occurs in vivo during HAV
infection is unknown. A significant level of seru IFN (8 U/ml)
was found in only 1 of 12 patients with acute HAV infection and
in only 1 of 39 other patients with acute HBV and NAN (Pugliese
et al., 1984), suggesting that IFN-activation of NK cells and NK
cell-mediated cytotoxicity may not be of clinical significance in
these disease processes.
In certain other human hepatitis virus infections, cell-
mediated imnity does not appear to be directly responsible for
the induction of liver imunopathology, since little inflamatory
cell infiltrate can be seen, even at the height of disease.
Rather, viral cytopathic effects seem more damaging to host
tissue. Some of the agents which comprise this class include
yellow fever (Howard et al., 1984), Ebola (Baskerville et al.,
1978), Congo-Crimean hemorrhagic fever (Baskerville et al.,
1981), and Lassa fever viruses (Winn and Walker, 1975). These
viruses may replicate lytically in lymphoid cells (Wheelock and
Edelman, 1969), resulting in direct imnosuppression and
lymphoid depletion, thereby crippling the ability of the host to
mount a strong cell-mediated response. Aggressive antiviral or
imnopotentiating intervention .early in infection might grant
the host time to generate sufficient cellular responses to combat
hepatitis viruses of this type. Studies of animal models
infected with attenuated or less virulent strains of some of
these viruses may allow an elucidation of the crucial components
of the cellular imune system that must preserved and promoted to
improve the prognosis of patients afflicted with these
potentially lethal infections.
CHAPTER II
MATERIALS AN METHODS
A. Animals
C57BL/6J (H-2b) and BALB/ cJ (H-2d) male mice were purchased
from Jackson Laboratories, Bar Harbor, ME. C57BL/6J (H-2
breeding stock (Jackson Labs) carrying the beige mut tion (
were bred and maintained in our facilities. C3H/St male mice
were purchased from West Seneca Farms, West Seneca, NY.
BAL/ cAnBOM athymic nude (ll/ll) mice and euthymic ll/+
littermates, derived from breeding stock generously provided by
. Dr. J. Ware (Duke University, Durham, NC), were bred in our
facilities and maintained in sterilized cages with autoclaved
food and bedding and acidified water. BALB/ cJ mice, congenitally
infected with LCMV (Traub, 1936), were bred in our biocontainment
facilities for infectious agents. Mice used in experiments were
between 6-12 weeks of age unless otherwise specified.
Hartley strain guinea pigs (GP) were obtained from Charles
River Laboratories, Wilmington, MA.
B. Cells and Media
L929 cells, a liver cell line from C3H mice (H-2k), MC57G
cells from C57BL/6 mice (H-2b), and Vero (African green monkey
kidney) cells were grown in monolayer culture in Eagle s minimal
essential medium (MEM; GIBCO, Grand Island, NY) supplemented with
10% heat-inactivated (56 oC, 30 min) fetal calf serum (FCSj M.
Bioproducts, Walkersville, MD), 2 mM glutamine, and
penicillin/ streptomycin (HE assay medium). YAC-1 cells (Fenyo
et al., 1968; Kiessling et al., 1975a), derived from a Moloney
leukemia virus-induced lymphoma in A/Sn mice (H-2 ), and K562
cells derived from a patient with chronic myelogenous leukemia
(Lozzio and Lozzio, 1975), were maintained in stationary
suspension culture in RPMI-1640 medium (GIBCO) with the above
supplements (RPMI assay medium).
HE assay medium and RPMI assay medium from which the FCS
had been omitted were termed HE wash medium and RPMI wash
medium, respectively.
C. Viruses
The hepatotropic WE strain (Welsh, 1984b) of LCMV (LCMV-WE),
the nonhepatotropic Armstrong strain (Welsh, 1978a) of LCMV
(LCMV-AR), and Pichinde virus (PV), an arenavirus related to
LCMV (Buchmeier et al., 1981) were stocks grown in L929 cells
(Welsh et al., 1976). Mouse hepatitis virus, strain A59 (MH;
Manaker et al., 1961) was prepared as a 10% homogenate of
infected liver tissue in HE that was clarified by centrifugation
(1500 g, 20 min, 4 OC), aliquoted, and stored at -70 oC. Murine
cytomegalovirus, Smith strain (MCMV; Smith, 1956), was a salivary
gland-grown stock prepared as described for MH from tissues- of
BALB/cJ mice at 2-3 weeks p. Vaccinia virus, strain WR (Natuk
and Holowczak, 1985), was propagated in Vero cells.
D. Rea ents
Poly-inosinic:poly-cytidylic acid (poly I :C), iodophenyl
nitrophenyl phenyltetrazolium chloride (INT), and metrizamide
were purchased from Sigma Chemical Co., St. Louis, MO. Hank'
balanced salt solution without Ca++ or Mg++ (HBSS) and Gey
solution were obtained from GIBCO. Cobra venom factor (CVF) was
purchased from Cordis Laboratories, Miami, FL. methyl- isatin
beta-thiosemicarbazone (MIBT) was a gift from Dr. C. Pfau,
Rensselaer Polytechnic Institute, Troy, NY. Purified mouse IFN-
beta was purchased from Lee Biomolecular Laboratories, San Diego,
CA.
E. Antisera and Com lement
Rabbit antiserum to ganglio-tetraosylceramide (asialo GM1;
Wako .Chemicals, Dallas, TX) was used to selectively deplete NK
cell acti vi ty in vivo and in vitro (Habu et al., 1981; Bukowski
et al., 1983b). For in vivo use, anti-asialo GM1 serum was
diluted 1:10 in RPMI 1640 medium, and 0. 2 ml was injected either
i. P . v.. Anti-asialo GM1 was used in vitro at a dilution of
1 : 50 . Monoclonal anti-Thy-1. 2, clone HO-13-4 (Ledbetter and
Herzenberg, 1979) (diluted 1: 1500), and J11d antibody (Bruce et
al., 1981) (used undiluted) were provided by Dr. R. Woodland
(University of Massachusetts Medical Center). Rat monoclonal
antibody to Lyt-2, clone 53-6. 7 (Ledbetter and Herzenberg, 1979),
was used undiluted. Rabbit serum (RbC), obtained from Pel-Freeze
Biologicals, Brown Deer, WI, was used as a souce of complement
(c) . Fresh guinea pig serum (GPC) was prepared from clotted
whole blood obtained by cardiac puncture of ether-anesthetized
guinea pigs and was used as an alternative source of C. Guinea
pig anti-LCMV serum was prepared from virus-immune guinea pigs
and was heat-inactivated (56 oC, 30 min) before use. Mouse anti-
LCMV serum was obtained from LCMV-immune mice' Guinea pig anti-
PV serum was a gift of Dr. M. Buchmeier (Scripps Clinic and
Research Foundation, La Jolla, CA).
For in vitro antibody and C depletion, effector cells (see
below) were treated with antibody reagent for 30-45 min at 4 oc
and then washed. Cells treated with anti-Lyt-2 were further
treated (to improve C fixation) with a 1: 50 dilution of
monoclonal mouse anti -rat immunoglobulin, MA 18. 5 (Lanier et
al., 1982), for an additional 30 min at 4 oc and then washed.
All cells were resuspended in C for 30 min at 37 oC, washed,
resuspended to equal volume, and used in cytotoxicity assays and
for the preparation of cytocentrifuge smears for differential
leukocyte counts.
F. In ections
Intraperitoneal (i.p. ) injections were performed without
anesthesia. Mice were injected i. v. by either of two routes:
injections via the lateral tail veins were aided by gently
heating the tail with a heat lamp to dilate the vessel; some mice
(ether-anesthetized) were inj ected i. v. via the retro-orbi tal
plexus. Mice injected with infectious agents were housed in the
Biocontainment Facility at UMC. Control, endogenous mice were
maintained in conventional housing quarters.
G. Pre aration of Effector Cells
1. S leen leukoc tes. Spleen cells were obtained by gently
dissociating aseptically removed spleens etween two frosted
glass microscope slides. Erythrocytes were lysed by treatment
with 0. 84% amonium chloride for 5 min. The leukocytes were
washed in RPMI wash medium, and the number of viable (0. 1% trypan
blue-excluding) cells was determined by hemocytometer counts.
The cells were resuspended in RPMI assay medium at the desired
concentration.
2 . Liver leukoc tes. Effector cells were prepared from livers
following in situ enzyme perfusion (David et al., 1975) with
modifications. Mice were anesthetized with sodium pentobarbital
(1. 0 - 1. 5 mg, i.p. ), or were decapitated and exsanguinated. The
abdominal cavity was opened by a ventral midline incision, and
the intestines were lifted to expose the portal vein. A silk
suture ligature was loosely placed around the portal vein 0. 5 cm
from the liver. The portal vein was then catheterized with
polyethylene tubing (0. 58 mm i. d., 0. 965 mm- d.; Becton
Dickinson, Parsippany, NJ), the ligature was tightened, and the
abdominal aorta was transected. Perfusion (2. 5 ml/min, 5 min)
was begun with heparinized (10 U/ml) Ca - and Mg -free HBSS at
3 7 C . This initial perfusion served to flush peripheral blood
from the organ. Only livers that were well-blanched were used
for further study. The perfusate was changed to pre-warmed HBSS
containing 0. 05% (w/v) collagenase (Type 1; Sigma) and 0. 05%
(w/v) neutral protease (dispase, Grade II; Boehringer Mannheim,
Indianapolis, IN), and the perfusion was continued or an
additional 10 min. The liver was then excised and teased apart
with forceps in HBSS containing deoxyribonuclease (100 U/ml, Type
1; Sigma) on ice for 15 min. The liver cell suspension was
passed through nylon mesh to remove clumps and pelleted at 1000
The pellet was resuspended in minimal volume (0. 5-0. 75 ml)
and mixed with isotonic 30% metrizamide in Gey s solution at a
ratio of 7 parts metrizamide solution to 5 parts liver cell
suspension (Wiltrout et al., 1984). This mixture was transferred
to a centrifuge tube, overlaid with 2 ml phosphate buffered
saline (PBS), and centrifuged for 20 min at 1500 g at 10 The
non-parenchymal cell layer was harvested from the interface,
washed in RPMI wash medium, counted, and resuspended to the
desired concentration in RPMI assay medium. This procedure
routinely yielded at least 2-5 x 106 non-parenchymal cells per
liver from control mice. In the experiments presented,
contaminating hepatocytes accounted for less than 1% of the total
cells recovered.
Plastic non-adherent liver leukocytes were used in some
experiments. They were obtained by incubating leukocytes (5 - 7
ml at 2 - 4 x t0 /ml RPMI assay medium) in 100 mm petri, dishes
for 1 hr at 37 o Nonadherent cells were recovered by
aspiration and washing of the plates.
H. C totoxicit assa
Target cells (106) were labeled with 100 uCi sodium chromate
(51Cr; New England Nuclear, Boston, MA, or Amersham Corp.,
Arlington Heights, IL) for 1 hr at 37 C, washed, and mixed with
effector cells in quadruplicate in round bottom microti ter wells
(Costar, Cambridge, MA) at 104 target .cells per well in a total
volume of 0. 2 ml RPMI assay medium supplemented with 10 ro N' - 2-
hydroxyethylpiperazine-N' -ethanesulfonic acid (HEPES). For
spontaneous release determinations medium was added without
effector cells. Nonidet P-40 (1%; SigmaY was added at the end of
the ass y for maximum release determinations. The plates were
incubated for 4-16 hr at 37 C in a humidified atmosphere of 5%
C02 and 95% air. At the end of incubation, plates were
centrifuged at 500 g for 5 min, and 0. 1 ml of the supernatant was
removed and counted in a Beckman gama counter (Model 5500;
Beckman Instruments, Palo Alto, CA). For the data presented, the
coefficient of variation among quadruplicate wells was less than
5%.
Data are expressed as % specific 51Cr release (or % specific
lysis) :
((cpm experimental - cpm spontaneous)/(cpm maximum - cpm
spontaneous) J x 100
In some experiments examining CTL activity, lysis is
expressed as: % virus-specific lysis = % specific lysis of virus
infected target minus % specific .lysis of uninfected target.
To compare the total lytic capabilities of effector
populations isolated from different organs, calculations of total
lytic units were computed by the formula: total lytic units =
(fraction of targets lysed x number of cells per organ) 
-effector: target ratio. An effector: target (E:T) ratio on the
linear portion of the cytotoxicity curve was used for these
calculations.
I. Virus ue assa
Organs were aseptically removed from mice at various times
p. i. Spleens were homogenized in 1 ml RPMI assay medium. Li vers
were weighed and then homogenized in 5 ml RPMI assay medium.
Tissue homogenates were clarified by centrifugation at 1500 g at
4 oc for 20 min. The supernatant was collected and titrated for
infectious virus immediately or aliquoted and stored at -70 o
until use.
LCMV and PV were titrated by plaque assays on Vero cells.
Plastic 60 mm petri dishes (Costar) with confluent cell
mono layers were infected with 100 ul of 10-fold serial dilutions
of blood or tissue homogenate in RPMI assay medium. The virus
was adsorbed for 1-2 hr at 37 Oc in a total volume of 1 ml with
occasional agitation of the dishes. The dishes were then
overlaid with 4 ml of a 42-45 Oc 0. 5% agarose solution, prepared
as follows: Agarose (type SeaKem HGT, FMC Corp, Rockland, ME)
(1%, w/v) was boiled in double-distilled water until dissolved,
then cooled to approximately 65 oc. To this was added an equal
volume of 2X concentrated ME with 2X glutamine, 2X antibiotics,
100 U mycostatin (GIBCO)/ml, and IX FCS. After allowing the
agarose to solidify at room temperature, the dishes were
incubated at 37 Oc in a humidified atmosphere of 5% C02 / 95% air
for 4- 5 days. The plaques were visualized by staining with the
addition of 1 ml of 0. 5% agarose solution containing 0. 01%
neutral red dye.
To discriminate between LCMV and PV in tissues of mice
dually infected with both viruses, PV w s titrated following
neutralization of LCMV with GP anti-LCMV serum. This was
accomplished by incubating 50 ul of clarified tissue homogenate
with 50 ul of a 1:4 dilution of heat-inactivated (56 oC, 30 min)
GP anti-LCMV serum for 45 min at 37 oC. Control tubes received
50 ul RPMI assay medium instead of GP anti-LCMV serum. Following
incubation, the contents were diluted to 0. 5 ml with RPMI assay
medium and titrated as above. LCMV was titrated- in the presence
of PV by staining plaque assay plates with 1 ml of iodophenyl
nitrophenyl phenyltetrazolium chloride (INT; 1. 5 mg/ml) in 0.
NaCl. This dye stains uninfected and PV - infected cells but not
LCMV-infected cells (Logan et al., 1975), thus LCMV plaques
appear clear on a stained background.
The titers of LCMV and vaccinia virus were discriminated in
tissues of dually infected mice by preparing plaque assay plates
essentially as described above. One set of plates was stained
with neutral red after 2 days incubation for the enumeration of
vaccinia virus plaques. N-methyl-isatin beta-thiosemicarbazone
(MIBT; 20 ug) was added at days 0 and 2 of incubation to the 4 ml
agarose overlay of the second set of plates to inhibit vaccinia
virus replication. LCMV plaques were demonstrated by staining
the plates after 4. days incubation.
J. Generation of alloreactive CTL
Lymph node cells (5 x 107) from normal BALB/cJ mice were
injected i. v. into C3H/St mice irradiated 1 hr earlier with 750 R
gama irradiation. - The spleens of recipient C3H/St mice were
harvested 5 days later and processed for effector cells as
described above.
K. Sur ical rocedures
Mice anesthetized by injection of sodium pentobarbital (1.
- 1. 5 mg, Lp. ), were shaved and then swabbed with ethanol and
iodine. A lateral incision was made through the abdominal wall.
In beta irradiation experiments (see below), the spleen was
exteriorized on its pedicle, wrapped in sterile gauze moistened
with saline, and immobilized. Following irradiation, the spleen
was replaced in the abdominal cavity, and the incision was closed
with stainless steel surgical staples.
For splenectomy, mice were similarly treated except that
following exteriorization of the spleen, a silk suture ligature
was tied around the pedicle and the spleen was excised. Sham-
operated mice underwent the same surgical treatment but without
the application of the ligature or removal of the spleen.
L. Irradiation of mice
Gama irradiation was administered to mice in a Gamacell 40
(Atomic Energy of Canada Limite , Ottawa, Canada), equipped with
twin 137Cs sources, at a dose rate of 125 R/min.
Electron irradiation (20 MeV) was delivered by a Saturne 20
linear accelerator (Thomson-CGR, Columbia, MD) at 300 R/min.
Shielding from electron irradiation was provided by inverted 5
ro-thick lead cups. Dosimetry measurements, conducted at the
time of irradiation with ionization chambers (PTW Corporation,
Freiburg, FRG), indicated that the lead shielding was )95%
effective in blocking exposure to electron irradiation.
M. Fluorescence- activated cell sorter FACS
Liver leukocytes were stained for FACS analysis and sorting
using rat monoclonal antibody 53-6. 7 against Lyt 2 followed by
F(ab' )2 mouse anti-rat immunoglobulin conjugated with fluorescein
isothiocyanate (Jacksonlmmunoresearch Labs, Inc., Avondale, PA).
Analysis and sorting were performed on a FACS 440 (Becton-
Dickinson FACS Systems, Mountain View, CA) at a laser output of
300 mW at 488 nm with green fluorescence collected through a DF
530/30 filter. Cells were separated into fluorescence-negative
and fluorescence-positive populations at a flow rate of 2 - 2. 5 x
103 cells/ sec.
N. Sin le cell C totoxicit assa
To directly visualize cytolysis mediated by dividing cells,
a single cell cytotoxicity assay (Grimm and Bonavida, 1979),
modified to include autoradiogr phy (Biron and Welsh, 1982), was
employed. Liver leukocyte effectors cells were prepared as
described above and given to Dr. C.A. Biron and K. F. Pedersen who
kindly performed the assay as described (Biron and Welsh, 1982).
Six hundred to 700 conjugates that contained a single effector
cell and a single target cell were scored per assay. The total
percent cytotoxicity is equal to the fraction of single cell
conjugates that contained dead target cells X 100. The percent
killing mediated by (3H-thymidine-incorporating') blast cells is
equal to (the number of single cell conjugates containing dead
target cells bound to blast cells / the total number of single
cell conjugates containing dead target cells) X 100. Viability
of the K562 target cells without added effector cells was greater
than 95%.
O. Centrifu al elutriation
Leukocytes were size-separated using a Beckman JE-6B
elutriation centrifuge (Beckman Instruments) essentially as
described (Kiessling et al., 1980; Biron and Welsh, 1982).
Leukocytes were loaded into the rotor spinning at 3200 rpm.
Fractions of increasing size (fractions 1 through 
respecti vely) were eluted in HBSS (with Ca ++ , Mg ++ and 1. 5 % FCS)
at flow rates of 15, 22, 28, 32, 38, and 48 ml/min at 4 oC.
P. Leukoc te mor holo
One to 3 x 104 leukocytes were centrifuged (650 rpm, 5 min)
onto glass microscope slides in a cytocentrifuge (Shandon
Southern Instruments, Inc., Sewickey, PA), air-dried,
stained with Wright' s and Giemsa stains. Two hundred to 500
leukocytes were counted under 100X oil immersion microscopy for
the emuneration of large granular lymphocyte (LGL) percentages.
The proportion of LGL exhibiting blast cell morphology (enlarged
cell size, basophilic cytoplasm, and/or prominent nucleoli (Hayry
and von Willebrand, 1981)) and of mitotic figures with
characteristic LGL cytoplasmic granules was determined by
counting 100-200 LGL and classifying them into blast or non-blast
LGL subsets.
. Histolo ical methods
The livers of mice were perfused in situ, using the
technique outlined above, with heparinized (10 U/ml) HBSS
containing Ca++ and Mg++ for 5 min at 2. 5 ml/min. For paraffin-
embedded techniques, the livers were fixed by perfusion for 10
min with 10% neutral buffered formalin. The tissue was processed
by conventional techniques, embedded in paraffin, sectioned, and
stained with hematoxylin and eosin (H&E). For immunofluorescence
studies, small blocks (approx. 2 x 2 x 5 mm) of spleen tissue
were mounted in O. T. compound (Miles Scientific, Naperville,
IL) and snap-frozen in liquid nitrogen. Four micron serial
frozen sections were fixed briefly in acetone then air-dried.
They were post-fixed for 10 min in cold acetone and washed in PBS
before immunostaining.
R. Statistical anal ses
Data are presented as the mean standard deviation, except
for data obtained from pooled samples. Statistical significance
between groups was determined by Student' s t test or the Fisher
exact test.
CHAPTER III
ROLE OF NK CELLS IN LCMV INFECTION
A. Acute infection
Considerable evidence has accumulated to date that NK cells
play little or no role in mediating antiviral effects during
acute LCMV infection (reviewed in Welsh, 1984b). Most of this
evidence has been acquired following infection by the Armstrong
strain of LCMV (LCMV-AR). It was of interest to determine
whether this apparent lack of NK cell involvement in acute LCMV
infection would also apply to infection with another LCMV strain,
the hepatotropic WE strain (LCMV-WE). While LCMV-AR grows only
to low titers ((3 log10 PFU/gm) in the liver during acute
infection (Welsh, 1984b), LCMV-WE replicates quite well there,
yielding titers 100- to 1000-fold higher by day 3 p. 
Mice were depleted of NK cells by injection of anti-asialo
GMI serum and then infected with LCMV-WE. As shown in Table 
LCMV-WE grew to comparable titers in the livers and spleens of
all mice at day 3 p. i., regardless of their NK cell status.
Thus, the replication of LCMV-WE does not appear to be under
regulation by NK cells, in agreement with previous work on LCMV-
AR (Bukowski et al., 1983b; Bukowski et al., 1985).
B. Persistent infection
Mice persistently infected with LCMV-AR have been shown to
Table 1
Effect of Anti-Asialo GM1 Treatment
In Vivo on LCM-WE Titers During Acute Infection
Lo910 PFU per
% YAC-1
Treatment sis leen Liver
None 21. :! 1.7 1 :! 0. 7 :! 0.
Anti-asialo GM1 -0. 2 :! 2. 1 :! 0. 9 :! 0.
Nine week old female C57BL/6J mice (n=4 per group) were in-
fected i.p. with 1x105 PFU LCM-WE. Organs were collected at day
3 p. i. and infectious virus titrated.
orne mice were treated i.v. 4 hr before infection with 0. 2 ml
anti-asialo GM1 seru (1:10 dil).
YAC-1 assays with spleen effector cells were run for 4 hr at E:T=50:1.
have elevated levels of NK cell activity and elevated levels of
circulating IFN (Bukowski et al., 1983a). To determine whether
NK cells in persistently infected mice might be exerting an
antiviral effect, anti-asialo GM1 seru was administered in vivo
to deplete NK cell acti ity, and the titers of infectious LCM in
various organs were determined 3 days later (Table 2). NK cell
activity was significantly reduced (p (. 01) by antiseru
treatment, but the depletion of NK cells had no significant
effect on LCM titers in blood, spleen, or liver (note that LCM-
AR grows well in liver during persistent infection in contrast
to acute infection). Since persistently infected mice make an
antiviral antibody response (Oldstone and Dixon, 1967), these
data also suggest that NK cells do not regulate, via their Fc
receptors, the persistent LCM-AR infection by antibody-
dependent cell-mediated cytotoxicity (ADCC).
C. Passive imization of LCM-infected mice
While NK cells were not apparently directly involved in
mediating anti-viral resistance either in acute LCM-WE infection
(Table 1) or in persistent LCM-AR infection (Table 2), the
possibility existed that an anti-LCM activity of NK cells,
mediated by ADCC, might be demonstrated in acute primy
infection. Norml mice were passively imunized with LCM-ime
seru prior to infection. LCM-imne seru was titrated in vivo
for its ability to inhibit subsequent LCM-AR infection
Table 2
Effect of Anti-Asialo GM1 Treatment
In Vivo on LCM Titers in Persistently Infected Mice
Lo910 PFU per
% YAC-1
Treatment e sis C leen Liver Brain
None 27. 6 :t 0. :t 0. :t 0".
Anti -asialo GM1 H 4. :t 0. :t 0. :t 0.
aBALB/cJ mice (n=3 per group) congenitally infected with LCM, were used
at 18 weeks of age.
ome mice were injected i. v. with 0. 2 ml anti-asialo GM1 seru (1:10
dil) 3 days before organs were harvested and titrated for infectious
virus.
YAC-1 assays with spleen effector cells were run for 16 hr at E:T=50:1.
, ,
(Table 3). A dose of 0. 1 ml LCMV - immune mouse serum was shown to
significantly (p (. 05) reduce LCMV spleen titers at day 3 p.
This dose of antiserum was used in the following experiments.
D. ADCC in acute LCMV infection
As shown in two separate experiments in Table 4, anti - LCMV
serum alone significantly reduced day 3 p. i. LCMV spleen titers
compared to infected controls (p (. 001 and p (. 01, Expt. 1 and 2,
respectively ) Depletion of NK cells by anti-asialo GMI serum
treatment concomitant with anti - LCMV serum inj ection yielded day
3 p. i. LCMV spleen titers that were not significantly different
than those in mice receiving anti-LCMV serum alone (p ). 10).
Note that infected mice receiving anti-asialo GMI alone had virus
titers that were not significantly different than titers in
infected controls. These data suggest that NK cells do not
significantly contribute directly, or indirectly via ADCC, to
host anti -viral resistance to LCMV.
A very potent, though non-specific, means for suppressing in
vivo host immune function is treatment with cyclophosphamide
(CY) . To examine whether a CY-sensitive component of the host'
immune system was interacting with antibody to lower viral titers
in this passive immunization protocol, mice were pre-treated with
CY then passively immunized and subsequently infected with LCMV.
Table 5 shows that while anti-LCMV serum again partially
protected mice from LCMV infection, no significant portion of
Table 3
Titration of Mouse Anti-LCM
Seru In Vivo During Acute LCM Infection
Antiseru Lo910 PFU
ected er S leen
None 1 :t 0.
1 :t 1.0
9 :t 0.
o . 025 9 :t 0.
Eleven week old C3H/St mice (n=3 per group) were in-
fected i.p. with 8x104 PFU LCM-AR 3 days before
organs were harvested for titration.
Volume of mouse anti-LCM seru diluted to 0. 2 ml and
injected i. v. at the time of infection.
Table 4
Effect of Anti-Asialo GM1 and Anti-LCM
Sera In Vivo on Acute LCM Infection
Anti-Asialo % YAC-1 Lo910 PFU
Strain Anti-LCM b GM1 c sis er S leen
C3H/St 52. :! 2. :! 0.
52. :! 5. 4 :! 0.
13. :! 4. 6 :! 0.
26. :! 7. 0 :! 0.
C57BL/6J 26. :! 5. :! 0.
38. :! 5. 1 :! 0.
:! 2. 1 :! 0.
5 :! 3. 1 :! 0.
C3H/St mice (n=4 per group); C57BL/6J mice (n=4 per group).
1 ml mouse anti - LCM seru i. v. at the time of infection.
2 ml anti-asialo GMl seru i. v. 4 hr before virus infection.
YAC-1 assays with spleen cell effectors were run for 16 hr at E: T=25: 1
(Expt. 1) or 4 hr at E: T=50 : 1 (Expt. 2).
Table 5
Effect of Cyclophosphamide (CY) and
Anti-LCM Seru on Acute LCM Infection
% YAC-1 Lo910 PFU
Strain Anti - LCM sis er S leen
C3H/ st 51. 5 :t 0.
35. 9 :t 0.
0 :t 0.
3 :t 0.
C57BL/6J 42. 4 :t 0.
39. 5 :t 0.
15. 3 :t 0.
18. 6:t 0.
C3H/St mice (n=3-5 per group) were 10 weeks of age andC57BL/6J mice
(n=3-5 per group) were 9 weeks of age.
b" Table 4.
cy (300 mg/kg, Expt. 1; 200 mg/kg Expt. 2) was inj ectad i. p. 48 hr
before infection. 
16 hr at E:T=25:1 (Expt. 1) or 4 hr at E:T=100:1 (Expt. 2).
this protection was CY-sensitive (compare anti-LCMV vs anti-LCMV
+ CY). In Expt. 1, mice treated with CY alone showed slight, but
statistically significant (p (. 01), reductions in LCMV titers at
day 3 p. i. This effect of CY was not seen in Expt. 2, possibly
because a lower dose of CY was employed in Expt. 2. Note that
CY-treated mice had considerably reduced NK cell activity,
providing further evidence against direct NK cell involvement in
LCMV infection.
Welsh et al (1976) showed that the addition of an active
source of complement (C) to antibody- coa ed LCMV virions led to
augmented in vitro inactivation of viral infectivity. The in
vivo interactions of passively transferred anti-LCMV antibody
with host C and host CY-sensitive components were examined by
treating mice with various combinations of anti-LCMV serum, CY.
and/ or cobra venom factor (CVF), which prevents complete
activation of the C system by depleting the third component of C
(C3) (Muller-Eberhard et al., 1966; Shin et al., 1969). Table 6
shows that pretreatment of LCMV-infected mice with CVF alone
(Group D) had no significant effect on LCMV spleen titers at day
3 p. i. compared to infected controls (Group A). However, if
passively immunized mice were pretreated with CVF (Group F), some
of the protective effect of anti-LCMV serum alone (Group B) was
lost (p (.05). This suggests that at least a portion of the
antiviral effect mediated by immune serum in vivo involved
binding and (presumed) activation of C components, by either
Table 6
Effect of Cyclophosphamide (CY), Cobra Venom
Factor (CV) and Anti-LCM Seru on Acute LCM Infection
Treatment % YAC-1 Lo910 PFU
Grou AntJ.-LCM sis er S leen
18. 5 :t 0.
22. 5 :t 0.
6 :t 0.
28. 6 :t 0.
6 :t 0.
30. 4 :t 0.
16. 3 :t 0.
10. 7 :t 0.
C57BL/6J mice (n=4 per group; except group G, n=3) were 9 weeks old.
"b" Table 4.
CY (300 mg/kg) was injected i.p. 48 hr before infection.
CV (15 U) was injected i.p. 4 hr before infection, and an additional
10 U injected i.p. at day 2 p.
YAC-1 assays with spleen cell effectors were run for 4 hr at E: T=50: 1.
antibody-coated virions or antibody-coated, virus-infected cells.
As seen previously (Table 5, Expt. 1), CY pretreatment alone
(Group C) caused a modest, yet significant (p (. 01), reduction in
viral titers compared to controls. The effects of CY and anti-
LCMV serum were not additive, however, as viral titers in the
presence of anti-LCMV serum without (Group B) or with CY (Group
E) were not different.
The antagonistic effect of C depletion on antiserum
protection could be overcome by the addition of CY to the
treatment regimen (Group H). Under these conditions (C-
depletion), the effects of CY and anti-LCMV serum appeared
approximately additive (compare Groups C, F, and H). The effect
of CVF plus CY (Group G) was not different than CY alone (Group
C), suggesting a lack of C involvement in the CY-induced
inhibition of LCMV synthesis.
The studies presented in this chapter provide further
evidence to substantiate the contention that NK cells play no
significant antiviral role in LCMV infections. Data supporting
this proposal were drawn from experiments of: i) acute infection
with two different strains of LCMV (Tables 1 and 4); ii)
persistent LCMV infection (Table 2); arid iii) passive
immunization studies in which no role for NK cell-mediated ADCC
could be shown (Tables 4, 5 and 6).
CHAPTER IV
SPECIFICITY OF ADOPTIVE IMMIZATION
The process of adoptive immunization has been successfully
employed to demonstrate the antiviral potential of virus-immune
spleen T cells in vivo (see Chapter I). The actual mechanism by
which immune T cells mediate this protection, however, is
uncertain. There are two prominent hypotheses to account for
this phenomenon. First, virus-specific CTL may lyse virus-
infected target cells in vivo in a - manner analogous to that seen
in vitro. Secondly, MHC class I-restricted virus-specific T
cells may release soluble factors with potential antiviral
activity following their recognition of appropriate antigens.
Either mechanism could adequately explain the currently available
data on antiviral adoptive immunization. The experiments
described below were performed to distinguish which of these two
possibilities is most likely responsible for the in vivo
antiviral effects of transferred immune T cells previously
described.
A. Ado tive immunization b alloimmune s leen cells
Alloimmune spleen cells were generated by injecting BALB/ 
(H-2d) lymph node cells into irradiated C3H/St (H-2 ) mice as
described in Materials and Methods. The in vitro cytotoxic
specificity of these cells for H-2k target cells is shown in
Table 7. The slightly elevated lysis of "uninfected" L929 cells
by LCMV-immune C3H/St splenocytes may have been due to infection
of some of the L929 cells with LCMV derived from the spleen
effector cells during the relatively long assay period.
Alloimmune (H-2d anti-H-2k) cells were then used to
adoptively immunize LCMV-infected C3H/St mice. The rationale for
this experiment was that, in the environment of an H-2k host,
these splenocytes would be stimulated by alloantigen to release
soluble factors (eg, immune interferon) which might have an
antiviral effect on LCMV replication. As shown in "Table 8,
however, no antiviral effect of adoptively transferred alloimmune
spleen cells was seen. In comparison, mice receiving syngeneic
LCMV - immune cells had s ignif icantly (p (. 001) reduced LCMV spleen
titers. Because of the short duration of the experiment (1 day),
it could not be documented that the transferred alloimmune cells
were actually functioning in vivo in the induction of a graft-vs-
host type reaction. Additionally, these intravenously injected
splenocytes may have been trapped in the lungs of the recipient
mice, and an antiviral effect mediated by the cells might not
have been evident in the spleen. Another system that would
provide an internal control for the in vivo activity of the
adoptively transferred cells was developed.
B. Ado tive immunization of duall virus-infected mice
1. LCMV and vaccinia virus. The rationale for the ' following
Table 7
In Vitro Cytotoxic Specificity of Alloimne Spleen Cells
% S ecific L sis
Effector Cells Vero P81S H-2 L-929 H-2
Alloimne (H-2d anti-H-2 -1. 7 -0. 89.
Normal C3H/St (H-2 -0.
LCM- Immne C3H/St 19.
Alloimne effector cells were prepared as described in Materials and
Methods. LCM-imune cells were obtained from 9 week old mice at day 8
i. with 8x104 PFU of LCM-AR.
Cytotoxici ty assays were run for 16 hr at E: T=6 . 1.
Table 8
Adoptive Imnization of LCM-Infected
C3H/St Mice with Alloimne Spleen Cells
Spleen LCM Titer
Cells Transferred Lo910 PFu/spleen
None 0 :t 0.
Normal C3H/St 8 :t 0.
LCM-irune C3H/St
Alloirune (H-2d anti-H-2
1.5 :t 0.
4 :t Ol5
Recipient mice (n=3 per group) were infected with
8x104 PFU LCM-AR i.p. 1 day before receiving
3x107 cells i. Alloirune cells were prepared
as described in Materials and Methods; LCM-
imne cells were from mice infected 8 days pre-
viously.
spleens of recipient mice were removed 1 day
after adoptive imnization.
series of experiments was similar to that described for the
alloimmune adoptive transfer studies above. Here, mice were
simultaneously infected with two different viruses (dually
infected) and then adoptively immunized with histocompatible
spleen cells immune to one of the two viruses. If protection was
mediated by nonspecific antiviral soluble factors, the titers of
both viruses might be expected to be reduced. Alternatively, if
protection was mediated by a specific mechanism such as direct
cytotoxicity, only the virus to which the spleen cells were
imme would be expected to be reduced in titer.
The first pair of viruses used in these studies was vaccinia
virus and LCMV (Armstrong strain). A plaque assay protocol was
developed to allow the differential titration of each virus in
the presence of the other (see Chapter II). This involved
preparing two parallel plaque assays for each tissue titrated.
The first of these was incubated for two days to allow for the
formation of vaccinia virus plaques and then stained.
detectable LCMV plaques were present at this time. The second
set of plates, containing N-methyl-isatin beta-thiosemicarbazone
(MIBT) in the agarose overlay to inhibit vaccinia virus
replication, was incubated for four days and then stained for
LCMV plaques. The effects of MIBT on the formation of vaccinia
virus and LCMV plaques are shown in Table In subsequent
studies (not shown), it was found to be necessary to add an
additional 5 ug/ml MIBT to the LCMV plaque assay plates at day 2
Table 9
Effect of N-Methyl-Isatin Beta-Thiosemicarbazone (MIBT)
and Dimethyl Sulfoxide (DMSO) on Plaque Formation
by Vaccinia Virus and LCM on Vero Cells
Vaccinia
Overlay Virus Titer
Additives (Lo910 PFU/ml)
None
DMSO: a .
MIBT: a . 2 ug/ml
MIBT: 1. a ug/ml
MIBT: 5 . a ug/ml
None
DMSO: a .
MIBT: a . 2 ug/ml
MIBT: 1. a ug/ml
MIBT: 5 . a ug/ml ( 1.0
Virus
LCM
Additive concentration in agarose overlay.
LCM plaques were stained after 4 days incubation and
vaccinia virus plaques after 2 days.
of incubation to completely suppress vaccinia virus replication
for the duration of the incubation period. This additional MIBT
had no apparent effect on LCMV titers.
Vaccinia virus-immune spleen cells were prepared at day 7
p. i. and tested for their cytotoxic activity in vitro. Table 10
demonstrates that these effector cells preferentially lysed
histocompatible target cells infected with vaccinia virus.
These effector cells were then used to adoptively immunize
mice infected with vaccinia virus alone, or mice dually infected
with vaccinia virus and LCMV. In Table 11 (Expt. 1), vaccinia
virus-immune spleen cells failed to successfully immunize either
singly or dually infected mice to vaccinia virus at day 1 after
cell transfer (p ). 05 vs recipients of normal cells). Waiting 2
days post-transfer of the immune cells before harvesting organs
(Expt. 2) yielded a reduction in titer that was statistically
significant (p (. 001). Vaccinia virus titers among individual
mice exhibited less variation at this time.
These experiments were repeated with the transfer of LCMV-
immune or vaccinia virus-immune spleen cells into dually infected
recipients (Table 12). In Expt. 1, LCMV - immune sp lenocytes
protected mice against LCMV (p (. 001) without significantly
reducing vaccinia virus titers (p ). 05). Similar results were
seen in Expt. 2 where LCMV-immune cells again significantly
reduced LCMV titers (p (. 01) but not vaccinia virus titers (p
05) . Vaccinia virus-immune spleen cells were successful in
Table 10
Generation of Vaccinia Virus-Immne Spleen Cells
% S ecific L sis b
L-929 L-929 + Vaccinia
Effector Cells 100: 1 50: 1 100: 1 50: 1
Normal 1.2 -1.0
Vaccinia Imne -0. 28. 21-
Vaccinia Imune -1.2 1.4 49. 32.
Six week old C3H/St mice were untreated (normal) or infected i.p. with
1x107 PFU vaccinia virus 7 days earlier (vaccinia imune).
b 51Cr release assays with pooled spleen effector cells (n=4-6 mice per
group) were run for 6 hr.
Table 11
Adoptive Immunization by Vaccinia Virus-Imne Spleen Cells
Virus Ti ter
Virus Spleen Cells Lo910 PFU/Spleen
VacciniaInoculated Transferred LCM
Vaccinia Normal :t 0.
Vaccinia Imune 1.5
Vaccinia + LCM Normal :t 0.
-'. '
Vaccinia Immne
Vaccinia Normal :t 0.
Vaccinia Immne
C3H/St mice (8 week old; n=4 per group) were infected i. p. with 1x10
PFU vaccinia virus alone, or with vaccinia virus and 8x104 PFU LCM
24 hr before cell transfer.
Spleen cells (3x10 7 ) were from normal or vaccinia virus-infected
(day 7 p. i. ) C3H/St donors.
Recipient spleens were titrated at 1 (Exp 1) or 2 (Ex 2) days after
cell transfer.
Table 12
Adoptive Imnization by !mne Spleen Cells:
Vaccinia Plus LCM Dually Infected Mice
Virus Titer
Virus Spleen Cells Lo910 PFU/Spleen
VacciniaInoculated Transferred LCM
Vaccinia + LCM Normal 9 :t 0. :t 0.
LCM Immune 4 :t 0. 1.5 :t 0.
Vaccinia + LCM Normal 3 :t 0. :t 0.
LCM Immne 8 :t 0. :t 1.1
Vaccinia Immune 5 :t 0. :t 0.
C3H/St mice (n=4-5 per group) were infected i. p. with 1xl07 PFU vac-
cinia virus and 8x104 LCM 1 day before cell transfer.
spleen cells (3x10 7 ) were from normal or day 7 p. i. LCM- or vaccinia
virus-imne C3H/St donors.
Spleens of recipient mice were titrated for virus 2 days after cell
transfer.
adoptively imm izing mice to vaccinia virus (p (. 01) but not to
LCMV . These data are consistent, therefore, with the hypothesis
that adoptive immunization by virus-immne spleen cells 
mediated in a highly specific manner (e.g., direct cytotoxicity)
rather than through the release of non-specific antiviral
factors.
2. LCMV and Pichinde virus. The experiments of adoptive
immunization to vaccinia virus (Tables 11 and 12) often led to
small, and sometimes statistically insignificant, reductions in
vaccinia virus titers. Another dual-virus system was thus
established, this time using two closely related arenaviruses,
LCMV and Pichinde virus (PV).
A plaque assay for the differential titration of LCMV and PV
in dually infected spleens was designed as outlined in Chapter
II. Briefly, PV was specifically titrated by neutralizing LCMV
with LCMV-immune guinea pig serum. LCMV was titrated by staining
plaque assay plates with INT which stains uninfected and PV-
infected cells but not LCMV-infected cells (Logan et al., 1975).
Thus, LCMV plaques appear clear on a stained background. Table
13 shows that treatment with GP anti-LCMV serum did not inhibit
PV infectivity and that INT stain was ineffective in
demonstrating PV plaques.
It was also necessary to demonstrate that virus-specific CTL
generated during PV and LCMV infections were not cross-reactive
in their lytic activity for target cells infected with the
Table 13
Differential Titration of P ichinde Virus (PV) and LCM
Plaque Assay Apparent Virus Titer
Log10 PFU/mlExp Virus GP Anti - LCM Stain
LCM Neutral Red
Neutral Red (2.
INT
Neutral Red
Neutral Red
INT (2.
LCM INT
Neutral Red
INT
Neutral Red
Aliquots of virus . stocks were untreated or treated with guinea pig (GP)
anti-LCM seru before titration as described in Materials and Methods.
plaque assay plates (vero cells) were stained at day 4 with neutral
red dye or iodophenyl nitrophenyl phenyltetrazolium chloride (INT) as
described in Materials and Methods.
heterologous arenavirus. This was shown to be the case as LCMV-
immune spleen cells lysed LCMV - infected targets, and PV - immune
spleen cells lysed PV-infected targets (Table 14). Neither
effector cell population lysed targets infected with the
heterologous virus to a significant degree, in agreement with
previous studies (Buchmeier et al., 1980).
Spleen cells from PV-infected mice were harvested at days 6-
9 p. i. and tested for their ability to adoptively immunize
recipient mice acutely infected with PV. The data in Table 15
demonstrate that all immune effector cell populations were
approximately equivalent in their ability to successfully
transfer immunity to PV compared to normal spleen cells (p (. 05 -
p (.
02). PV-immune cells obtained at day 7 p. i. were chosen for
the remaining experiments. Addi tionally, two days were allowed
to elapse following cell transfer in the hope of achieving a
greater reduction in virus titer than that seen earlier (Table
15) where spleens were harvested 1 day after transfer.
LCMV-immune or PV-immune spleen cells were transferred to
recipient mice acutely infected with either LCMV, PV, or both
viruses. Table 16 (Expt. 1) shows the results of transferring
LCMV-immune spleen cells to singly and dually infected mice.
Compared to normal spleen cells, LCMV - immune spleen cells
significantly (p (. 001) reduced LCMV titers in mice infected with
LCMV alone, but not in mice infected with PV alone. In mice
infected with both viruses, only the LCMV titers were reduced (p
Table 14
In Vitro Cytotoxic Specificity of Virus-Immne Spleen Cells
% S ecific L sis b
leen Cells L-292 L-929 + PV L-929 + LCM
Normal C3H -1.0
LCM- Imne 32.
PV- Immne 1.1 33.
Spleen cells were from normal or day 7 virus-imune C3H/St mice.
cytotoxici ty assays were run for 6 hr at E: T=50: 1.
Table 15
Adoptive Immnization by PV-Immne
Spleen Cells Prepared at Different Times Postinfection
Virus Titer
Spleen Cells Transferred Lo910 PFU/Spleen
Normal
Day 6 Immune
Day 7 Immne
Day 8 Immne
Day 9 Immune
3 :t 0.
5 :t 0.
7 :t 0.
5 :t 0.
7 :t 0.
Spleen cells were from normal or PV-infected (lx106 PFU
i.p. ) C3H/St mice t various days p. Cell transfers
( 3x10 7 i. v. ) were all performed on the same day into
C3H/St mice infected i.p. 1 day earlier with PV.
spleens of recipient mice (n=3 per group) were titrated
.;:.
2 days after cell transfer.
Virus
Inoculated
LCM
LCM + 
LCM
LCM + 
Table 16
Specificity of Arenavirus-Imne
Spleen Cells in Adoptively Immnized Mice
Virus Titer
Spleen Cells Lo910 PFU/Spleen
Transferred LCM
Normal 9 :!
LCM- Immne 4 :!
Normal 2 :!
LCM- Immne 4 :!
Normal 5 :! 1 :!
LCM- Imne 5 :! 8 :!
Normal 4 :!
PV- Imne 6 :!
Normal 4 :!
PV- Immne 2 :!
Normal 6 :!
PV- Imne
:! 
5 :!
Table 16 (cont' d)
C3H/St mice (n=4 per group) were infected with LCM (8x104 PFU i.
PV (lx106 PFU i. v. ) or both viruses 24 hr before cell transfer.
Mice received 5 (Ext . 1) or 8 (Ext . 2) x107 normal or day 7 virus-
imune C3H/St spleen cells i. v.
Spleens of recipient mice were removed and titrated for virus 2 days
after cell transfer.
05) while PV titers were unaffected. In the reciprocal
experiment (Table 16, Expt. 2), PV-immune spleen cells were
adoptively transferred. These cells had no effect on LCMV titers
in mice singly infected with LCMV or in dually infected mice.
However, PV titers were significantly reduced in mice singly
infected with PV (p (. 05) or dually infected with PV and LCMV (p
001). In these experiments, therefore, the specificity of
adoptive immunization against arenavirus infection in vivo (Table
16) correlated with the specificity of virus-immune CTL
recognition patterns in vitro (Table 14).
To examine the possibility that the fine specificity of the
immunizing cells was due to low titers of the two viruses growing
in widely separated regions of the spleen at the time of adoptive
transfer (day 1 p. i. ), recipient mice were lethally irradiated
(1000 R, gama irradiation) to suppress their own immune
response, which would allow for a longer time of infection, and
then dually infected with LCMV and PV. These mice were
adoptively immunized with LCMV-immune cells on day 3 p. i. and
spleen virus titers were determined 2 days after cell transfer.
The data in Table 17 again demonstrate the specific reduction of
LCMV titers in the spleen following LCMV-immune cell transfer
wi th no effect observed on the heterologous PV titers:
3. Localization of LCMV and PV anti ens in duall infected
leens. In a parallel experiment, the spleens of lethally
irradiated, dually infected mice were obtained 3 days p. i. and
Table 17
Adoptive Imnization of Lethally Irradiated, Dually Infected Mice
Virus Ti ter
Lo910 PFU/Spleen
leen Cells Transferred LCM
Normal 3 . 4 :t . 0 :t .
LCM- Imne 4 :t . 7 :f . 32*
Recipient C3H/St mice (n=4 per group) were irradiated (1000 R gama
irradiation) and then infected with 8x104 PFU LCM i.p. and 1x10
PFU PV Lp.
On day 3 postinfection, mice received 5x10 7 normal or day 7 LCM-
imune C3H/St spleen cells i. v.
Spleens of recipient mice were removed 2 days after cell transfer
for titration of virus.
processed for virus-specific immunofluorescent staining. Serial
four micron frozen sections were stained with LCMV- or PV-immune
guinea pig sera. Side-by-side comparison of these sections
(Figure 1) indicated that both viruses were indeed growing in
very close proximity to one another at the time of adoptive
immunization.
Thus, under the present conditions where transferred virus-
immune splenocytes were stimulated by antigen to which they had
been primed, no non-specific antiviral effect was evident. These
results support the concept that T cell-dependent adoptive
immunization involves an extremely localized antiviral effect by
the immune splenocytes, and the data are consistent with a mode
of action involving direct cytotoxicity.
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Figure 1. Localization of LCM and PV antigens in spleens of
dually infected mice. Four micron serial sections of dually
infected spleens were incubated with LCM- or PV-imune guinea
pig seru, washed, and stained with rhodamine-conjugated goat
anti-guinea pig seru. Neither virus-specific antiseru stained
un infected spleens or spleens singly infected with the
heterologous virus (not shown). Panel A (LCM antigen) and panel
B (PV antigen) represent the same area of adj acent sections.
Panel C is a composite drawing (LCM antigen , solid lines; PV
antigen, dotted lines) made by superimosing panels A and 
Original magnification X 400.
CHAPTER V
CELL-MEIATED IMMITY IN VIRA HEPATITIS
The liver is a major organ for the replication of many
viruses and the sole organ for , the replication of some.
Virus-induced hepatitis is frequently a severe life-threatening
disease affecting millions of people worldw de, but little is
known about the cytotoxic inflamatory cell population within the
diseased Ii ver The following section of the thesis analyzes the
nature of the inflamtory cell infiltrate in the liver during
the course of viral hepatitis induced by infection with several
viral agents.
A. Effect of erfusate enz e concentration on leukoc te ields
from erfused livers
In preliminary experiments (not shown), a variety of
different enzymes were tested for their ability to aid in the
dissociation of the liver into a single cell suspension following
in situ perfusion. The enzymes examined individually and in
various combinations included collagenase (types I and IV),
pronase, hyaluronidase, and dispase (rieutral protease).
combination of collagenase (type I) and dispase appeared to be
promising in initial trials and was examined more closely,
varying the concentrations of the two enzymes (Table 18). Since
it was deemed desirable to minimize potential proteolytic damage
Table 18
In Situ Liver Perfusion: Effect of Enzyme
Concentration on Leukocyte Yield
Enz e Concentration Total Leukocytes
er Liver X10 Colla enase Dis ase
10.
025 025
Livers of C57BL/6J mice (6 week old) were perfused as
described in Materials and Methods, except the enzyme
concentrations listed were employed.
to leukocyte cell surface proteins and receptors while maximizing
cell yields, th intermediate enzyme concentrations of . 05%
collagenase and . 05% dispase (Table 18) were used in all
subsequent perfusion studies.
B. Effect of enz es on s leen NK cell activit
Since enzyme perfusion was used to isolate liver leukocytes,
it was not possible to determine the effects (if any) of in situ
enzyme exposure on these cells. The enzymes were tested for
their effect on NK cell lysis mediated by spleen cells. Spleen
cells were exposed to collagenase and dispase in vitro for a time
period equivalent to the period of exposure of liver leukocytes
to enzyme in situ. Table 19 shows that exposure of spleen cells
to enzyme had no diminishing effect on their NK cell activity.
Rather, enzyme exposure may actually have had a slight enhancing
effect on lysis. However, since liver leukocytes from all mice
would be exposed to the same enzymes during in situ perfusion,
this minor effect on lytic activity would likely be uniform and
was not taken into account in further determinations of cytotoxic
activity.
C. Com arison of he atotro ic and non-he atotro ic LCMV
infections
The induction of NK cell and CTL activities and the
accumulation of LGL in the liver were studied on days 1-14 p. i.
70-
Table 19
Effect of Enzyme Treatment on Spleen NK Cell Activity
Enz e Concentration % S ecific sis
YAC-1 L-929
13.
16.
18.
15. 1. 7
Coll enase Dis ase
025 025
Aliquots of endogenous (normal) C57BL/6J spleen cells (3. 5x10 ) were
incubated for 15 min at room temerature in HBSS containing the in-
dicated concentrations of enzymes. Deoxyribonuclease was added
(100 U/ml final concentration) and incubation continued for an
addi tional 10 min. The cells were washed and resuspended for use in
Cr release assays.
Cytotoxici ty assays were run for 4 hr at E: T= 100: 1.
in animals infected i.p. with either LCMV-AR or LCMV-WE.
LCMV-AR is generally non-hepatotropic and grows poorly in the
iver during acute infection, whereas the LCMV-WE strain is
hepatotropic and replicates in the liver to high titer (Welsh,
1984b) . Both viruses induced an increase in NK cell activity
detected against both YAC-l and L929 cells by day 1 p. i. that
peaked at days 3-5 p. i. and declined thereafter (Figure 2D and
2E). The appearance and progressive increase of NK cell activity
through day 5 p. i. were paralleled by a progressive increase in
LGL number beginning on day 1 p. i. (Figure 2B). Virus-specific
CTL activity began to increase on day 5 p. i. with both viruses
and peaked on day 7 p. i. (Figure 2F). By day 7 p. i., the LCMV-WE
infection induced an average 28-fold increase in the number of
liver leukocytes, while the LCMV-AR infection induced only a
5-fold increase (Figure 2A). These differences in total
leukocyte number were confirmed histologically: LCMV-WE-infected
livers had markedly greater infiltrations of mononuclear
inflamatory cells than LCMV-AR-infected livers (Figure 3). The
centers of focal accumulations of mononuclear cells occasionally
contained one or two necrotic hepatocytes with pyknotic nuclei
and intensely eosinophilic cytoplasm. Because LCMV is relatively
. non-cytopathic (Welsh and Pfau, 1972), it is likely that
hepatocyte death results from an immunopathological mechanism
(see Chapter I). When the total lytic capacities of the liver
leukocyte populations were calculated, the LCMV-WE infection
tee
508 580
480 4a9
:. 300
i 280
Z 200
; 180 t00
DAYS PDST- INFECTION DAYS POST- INFECTION
Figure
Figure 2. Kinetics of the appearance of LGL and of NK cell and
CTL cytotoxic activities in the livers of C3HjSt mice infected
with LCM-AR (dotted line) or LCM-WE (solid line). A. Total
leukocytes per liver. B. Total LGL per liver. C. Percent LGL in
the leukocyte population. D. Percent specific 51Cr release from
L929 targets at E: T=10 in 12 hr assay. E. Percent specific 51
release from YAC-1 targets at E:T=10 in 4 hr assay. F. Percent
specific 51Cr release from LCM-infected L929 cells at E:T=10 in
12 hr assay. G. NK cell lytic units per liver (calculated from %
YAC-1 lysis as described in Materials and Methods). H. CTL lytic
units per liver (calculated from % virus-specific lysis as
described in Materials and Methods).
Figure 3
Figure 3. Day 7 p. i. liver histology of C3H/St mice infected
with LCM-AR (Panel A) or LCM-WE (Panel B). Livers of LCM-
infected mice were fixed by perfusion with 10% formalin at day
7 p. i. Note the greater numers of mononuclear inflamatory
cells in the parenchyma of the LCM-WE-infected liver.
Hematoxylin and eosin, X 100.
resul ted in 10-fold higher total CTL lytic units on day 7 p. i.
than did LCMV-AR infection (Figure 2H). The levels of day 7 CTL
activity closely correlated with the total numbers of LGL
isolated on day 7 from the livers of mice infected with LCMV-WE
or LCMV-AR (Figure 2B).
D. Characterization of da 3 and da 7 C totoxic effector cells
The patterns of cytotoxic activities present at days 3 and 7
p. i. (Figure 2) were suggestive of the NK cell and CTL lytic
profiles reported previously in the spleen (Welsh, 1978).
further characterize these effector cell populations, liver
leukocytes were treated with various antibodies and complement
(c) in vitro. The cells remaining after. treatment were tested
for cytotoxic activity and were examined for the presence of LGL
on stained cytocentrifuge smears. The data in Table 20 (Expt. 1)
indicate that day 3 cytotoxic activity against YAC-l cells was
completely sensitive to treatment with anti-asialo GMI + C and
slightly reduced by anti -Thy 1. 2 + C. Treatment with C and Jlld
antibody (recognizing a marker on granulocytes and B cells (Bruce
et al., 1981)) had no effect on lysis. Changes in the number of
cells morphologically identified as LGL paralleled the changes in
lytic activity: anti-asialo GMI + C treatment markedly reduced
the number of LGL, anti-Thy 1. 2 + C resulted in a partial
depletion (64%), and Jlld + C was without effect on LGL number.
Thus, the phenotype for the day 3 p. i. effector cells is
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consistent with the reported phenotype of NK cells (Biron, 1986):
asialo GMl ' Thy 1. 2+/- , Jlld- , YAC-l. killer, and LGL morphology.
. Liver leukocytes isolated at day 7 p. i. were treated with
antibody reagents known to react with determinants present on
CTL. As shown in Table 20 (Expt. 2), treatments with either
anti-Jhy 1. 2 + C or anti-Lyt 2 + C significantly reduced the
virus-specific lysis of infected target cells. These treatments
also resulted in the depletion of a significant proportion of the
LGL from the effector cell population.
To further confirm the surface phenotype and LGL morphology
of effector cells obtained at days 3 and 7 p. i. with LCMV, liver
leukocytes were examined by FACS analysis following staining with
monoclonal anti-Lyt-2 antibody. Eleven percent of the day 3 p. i.
liver leukocyte population was Lyt-2+ (Table 21). The vast
majority (89%) of day 3 p. i. leukocytes were Lyt-2- , and 13% of
these cells were LGL. The Lyt-2- LGL accounted for 77% of all
LGL present at day 3 p. i., and this population was enriched for
NK cell activity. No virus-specific lytic activity was
detectable at this time p. i. in any population.
In contrast to day 3 p. i. leukocytes, twenty- seven percent
of the day 7 p. i. liver leukocyte population was Lyt-2+
sorted Lyt-2+ cells were enriched at least two-fold for
FACS-
virus-specific lytic activity compared to stained but unseparated
cells, while NK cell activity was reduced (Table 21).
Table 21
Lyt-2 Phenotype of LGL at Days 3 and 7 p. i. with LCM-AR
Cell % Virus- % YAC-1
ulation % LGL ecific sis sis
Day 3 Lyt-2+ (11) 34 (23) " 1
Lyt-2 (89) 13 (77) " 1
Unsorted " 1
Day 7 Lyt-2+ (27) 42 (58)
Lyt-2 (73) 13 (42) 16.
Unsorted
Liver leukocytes from C3H/St mice at day 7 p. i. with LCM-AR were
stained with monoclonal anti-Lyt-2 antibody and sorted into Lyt-2+ and
Lyt-2- populations. Values in parentheses indicate the percentage of
all cells of a particular type expressing the indicated Lyt-2 phenotype.
NK c ll assays against YAC-1 targets were run for 4 hr at E/T of 3: 1,
and CTL assays against un infected and LCM- infected L-929 cells were
run for 14 hr at E/T of 3: 1.
Conversely, while Lyt-2- cells were depleted of virus- specific
cytotoxic effectors, they were enriched for cells expressing NK
cell activity. Lyt- + cells were enriched almost two-fold for
cells possessing LGL morphology, and they accounted for 54% of
all LGL present. Day 7 p. i. Lyt-2- cells were LGL-depleted
compared to unfractionated cells (Table 21). Thus, CTL activity
and cells bearing LGL morphology were found to co-purify in a
population of leukocytes expressing the CTL marker Lyt-2.
E. C totoxict
y p
attern of da ost-LCMV infection liver
leukoc tes
Spleen CTL induced during LCMV infection are virus- specific
and H-2-restricted effector cells (Zinkernagel and Doherty,
1975) . When tested for lysis against various targets, liver
effector cells isolated from C3H/ St mice at day 7 p. i. had
typical CTL killing patterns (Table 22).
strongly lysed LCMV-infected histocompatible cells (L929 + LCMV)
These effectors
but not LCMV-infected histoincompatible cells (MC57G + LCMV).
They also exhibited minimal lysis against histocompatible cells
either uninfected or infected with Pichinde virus (L929 + PV).
Earlier experiments Table 14) showed that PV-infected cells were
highly sensitive targets for PV-immune CTL. These experiments
confirm that the effector cells isolated from liver at day 7 p. i.
with LCMV contain classical virus-specific CTL.
Table 22
Cytotoxicity Pattern of Day 7 p.
Effector Cells From LCM-AR-Infected Liver
E:T % S ecific L sis
Ratio L-929 L-929 + LCM L-929 + PV MC57G + LCM
-0.
Liver leukocytes from C3H/St mice (H-2 ) at day 7 p. i. with LCM-AR
were tested for lytic activity against uninfected L-929 cells (H-2
L-929 cells infected with LCM (L-929 + LCM) or Pichinde virus (L-929 +
PV), and MC57G cells (H-2 ) infected with LCM (MC57G + LCM) in 12 hr
cr-release assays
:-.
F. Adherence erties of liver NK/LGL
Liver leukocytes were isolated from control and poly I:C-
treated mice. Plastic-adherent cells were removed by incubation
in plastic petri dishes. NK cell lytic activity for YAC-l
targets was enriched in non-adherent populations from both
control and poly I:C-activated liver leukocytes (Table 23).
While cells with LGL morphology were enriched in the non-adherent
leukocyte fraction from poly I:C-treated mice, a similar
enrichment was not observed for control liver leukocytes. The
reason for this apparent difference in adherence between control
and activated NK/LGL may be related to a lesser depletion of
macrophage and non-granular lymphocytes from the control
leukocytes than from the poly I: C-treated leukocytes (data not
shown), resulting in no overall enrichment of LGL in the non-
adherent control population.
G. De letion of LGL in vivo
Mice were treated in vivo with anti-asialo GMI at the time
of viral infection, and liver leukocytes and splenocytes were
isolated at day 3 p. Table 24 (Expt. 1) demonstrates that in
vivo anti-asialo GMI serum treatment was highly effective (p
01) at depleting NK cell activity (YAC-1 lysis) in both the
liver and spleen during virus infection. This treatment also
significantly reduced both the percentage (p (. 001) and absolute
number of LGL (p (. 001) in the liver leukocyte population without
Table 23
Adherence Properties of Liver-Derived NK/LGL
Liver Leukoc tes Treatment % LGL % YAC-1 sis
control Unseparated 17.
Non-adherent 25.
Poly I:C Unseparated 62.
Non-adherent 75.
Liver leukocytes were pooled from control or day 2 poly I:C-injected
(100 ug i
.p.
) C57BL/6J mice.
Non-adherent cells were prepared as described in Materials and Methods.
4 hr assays, E:T=33:1.
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reducing the total number of liver leukocytes present in these
animals.
The sensitivity of the generation of the day 7 effector
cells was similarly tested. In contrast to the day 3 NK/LGL, the
accumulation of day 7 CTL/LGL in the liver was relatively
resistant to a double treatment in vivo with anti-asialo GM
serum (Table 24, Expt. 2). This treatment eliminated most of the
relatively low level of NK-like cytotoxicity against YAC-1 cells
(p (.
05) without reducing the CTL-like cytotoxicity on
LCMV-infected L929 cells.
H. LGL res onse in C57BL/6J mice
To be certain that the differential in the liver-associated
CTL response during LCMV-WE infection vs. LCMV-AR infection was
not peculiar to the C3H/St mouse strain, C57BL/6J mice were
infected with LCMV-WE or LCMV-AR, and the CTL responses were
compared. Livers of C57BL/6J mice infected with LCMV-WE had
significantly higher numbers of total leukocytes (p (. 02) and
total LGL (p (. 001) as well as 2-foldhigher CTL lytic units than
did those from LCMV-AR-infected mice (Table 25). These results
were similar to those observed with C3H/St mice (Figure 2).
Surprising, however, was the finding that this difference in the
liver CTL/LGL activity was manifested despite very low levels of
CTL activity in the spleens of the LCMV-WE-infected mice (Table
25) . The spleens from the LCMV-WE-infected mice were smaller and
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contained 67% fewer leukocytes than spleens from LCMV-AR-
infected mice. Thus, C57BL/6J mice infected with either strain
of LCMV were capable of mounting a CTL response, but that
response was concentrated almost exclusively in the livers of
mice infected with hepatotropic LCMV-WE, whereas the CTL response
predominated in the spleens of mice infected with non-
hepatotropic LCMV-AR.
I. Th ic de endence of leukoc te accumlation
The reason for the large increase in total liver leukocytes
following LCMV-WE infection as compared to LCMV-AR infection
(Figure 2, Table 25) was unclear. To determine whether specific
T cell-mediated immunity played a role in this difference, T
cell-deficient BALB/c mice and immunocompetent 
littermates were infected with either LCMV-AR or LCMV-WE, and
liver leukocytes were isolated at day 7 p. The data in Table
26 indicate that the T cell- sufficient /+ mice infected with
LCMV-WE accumulated more liver leukocytes than did /+ mice
infected with LCMV-AR (p (. 01). This appeared to be thymus-
and, therefore, probably T cell-dependent, as mice infected
with either LCMV-WE or LCMV-AR had lower numbers of liver
leukocytes than /+ mice infected with LCMV-WE.
Table 26
Inflamatory Cell Responses in Liver
at Day 7 p. i. with LCM-WE are Thyms Dependenta
Mouse Strain Virus Strain
Total Leukocytes per
Liver (x 10
nu/nu
nu/+
nu/nu
nu/+
8 :t 1.9LCM-AR
LCM-AR 12. :t 2.
LCM-WE
LCM-WE
9:t 1
37. :t 5.
BALB/c nu/nu and nu/+ mice were infected with LCM-AR or LCM-WE and
liver leukocytes were isolated at day 7 p. i. as described in Materials
and Methods.
4":'"
J. Au entation of liver NK/LGL b other virus infections or
I:C
The effects of poly I: C or infection by several viruses on
liver NK/LGL were compared in different mouse strains (Table 27).
C57BL/6J mice treated with poly I:C (Expt. 1) or infected with
the non-cytopathic LCMV-AR (Expt. 2) had comparable increases
(2-3-fold compared to controls) in total LGL and in lysis of
YAC-1 cells. In vivo treatment with anti-asialo GMI serum
abrogated NK cell activity and LGL accumulation in both cases
(Expt. 1 and 3). However, total numbers of liver leukocytes in
the treated animals were only minimally changed from control,
whether or not the mice received anti-asialo GMI injections.
NK cell-deficient C57BL/6J mice homozygous for the beige
mutation (Eg/Eg) were compared with NK cell- sufficient Eg/+
littermates at day 3 p. i. with LCMV-AR for liver NK/LGL lytic
activity and cell number (Expt. 4). C57BL/6J Eg/Eg mice had
markedly reduced NK cell activity associated with liver
leukocytes, despite having higher percentages and higher total
numbers of LGL than / + mice. However, the majority (76%) of
the liver LGL present in the Eg/Eg mice bore the atypical
morphology characteristic of LGL from beige mutant mice (Itoh et
al., 1982), i. e., one to three abnormally large cytoplasmic
granules rather than the numerous small granules of normal LGL
(see Figure 4 for normal morphology). The NK cell activity and
accumulation of NK/LGL in the livers of heterozygous 
/+ mice
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(Expt. 4) were similar to those seen in C57BL/6J (+/+) mice
(Expt. 2 and 3).
These results showing only modest increases in total
leukocyte and LGL number during LCMV infection contrast with the
findings at day 3 p. i. in C57BL/6J mice infected with the
cytopathic hepatotropic viruses, MCMV (Expt. 5) or MH (Expt. 6).
These virus infections increased the total leukocyte number
2-5-fold, LGL percentages 3-4-fold, and the total LGL number from
7-22-fold. NK cell activity (YAC-1 lysis) was also markedly
increased in the MCMV - and MH - infected mice. As also shown
above for poly I:C and LCMV-AR, anti-asialo GM1 treatment
abolished the NK/LGL increases induced by MH (Expt. 7). MH .
infection of C57BL/6J mice also resulted in a significant
(p (.
01) increase in NK/LGL in the liver, but these cells were
relatively inefficient in lysing YAC-1 targets (Expt. 8).
NK/LGL responses in normal BALB/cJ and in T cell-deficient
nude ( ) BALB/ c mice were examined. Following LCMV-AR
infection, BALB/ cJ mice (Expt. 9) were found to produce NK/LGL
responses comparable to those seen in either C57BL/6J or C3H/St
mice. In BALB/c mice, poly I:C treatment and LCMV-AR
infection induced similar increases (Expt. 10). When and
/+ mice were compared within the same experiment, poly I:C
treatment induced higher YAC-1 lysis and % LGL in 
than in
/+ mice (Expt. 11). This is in agreement with previous
observations of higher levels of endogenous (Stitz et al., 1985)
and activated (Leung and Ada, 1981; Taylor et al., 1985) NK cell
activity in than in /+ mice
Thus, these experiments (Table 27) demonstrate that NK cell
activity and LGL number in the liver are increased early
following virus infection or treatment with the IFN-inducer poly
I:C. These NK/LGL increases occur in several strains of mice,
including strains with genetic defects in NK cell ) and T
cell ( ) activity.
K. Multi le activation of liver NK cell activit
The ability of sequential treatments with IFN-beta and the
IFN-inducer poly I:C to maximize NK/LGL accumulation and lytic
activity in the liver was examined. A single injection of IFN-
beta (105 U) augmented liver NK cell activity and LGL percentage
within 24 hr (Table 28). Two treatments (at a four day interval)
with IFN or IFN-inducer resulted in maximal LGL accumulation and
NK cell activity; a third treatment provided no further increase.
These data suggest that NK/LGL may become refractory to repeated
stimulation by IFN as has been shown following multiple
stimulations of NK cell activity with other biologically active
substances ( Saito et al., 1985; Talmadge et al., 1985).
L. Kinetics of NK/LGL accumulation durin MH infection
C57BL/6J mice were infected for 1 to 3 days with MH before
leukocytes were isolated from their livers. Table 29 indicates
Table 28
Multiple Activation of Liver NK Cell
Activity by Interferon and Interferon-Inducer
% YAC-1 Total Leukocytes Total LGL
Treatmenta sis er Liver 10 % LGL er Liver 10 
None
IFN (D-1) 12. 11.
Poly I:C (D-5)
+ IFN (D-1) 16. 12. 14. 17.
Poly I:C (D-9) +
IFN (D-5, D-1) 10. 13. 12. 16.
BALB/c nu/+ mice (n=2 per group) were untreated or injected i.p. with
100 ug poly I:C and/or injected i. v. with 1 x 105 U IFN-beta on the
days indicated before harvest. Liver leukocytes were prepared from all
mice on the same day and pooled within groups.
byAC-1 assays were run for 4. 5 hr at E:T = 33:1.
Table 29
Kinetics of NK/LGL Accumlation During MH Infection
Day % YAC-1 Total Leukocytes Total LGL
Postinfection sis er Liver x10 % LGL er Liver 10'
(control) 12. :t6 . 5 9 :t 1.3 4 . 7:t0 . 6 1.9 :t 0.
25. :t3. 0 :t 0. 6. 0:t1. 0 1.2 :t 0.
27. :t2. 0 0 :t 0. 7:t3. 1.2
36. :t6. 7 0 :t 1.4 12. :t4 . 0 7 :t 1.5
C57BL/6J mice (n=3 per group) were uninfected (Day 0 control) or in-
fected i.p. with MH. Liver leukocytes were prepared from all mice on
the same day.
byAC-l assays were run for 5 hr at E: T = 7: 1.
that as early as day 1 p. i. an increase in NK cell activity (YAC-
1 lysis) was evident, despite no increase in LGL percentage.
This suggests that the increased lytic activity was due to
activation of NK cells by virus-induced IFN and not by increased
proportions of NK cells in the leukocyte populations. LGL
percentage began to rise noticeably by day 2 p. i., with NK cell
activity, LGL percentage, and total LGL number reaching high
levels by day 3 p. 
M. Virus vs NK/LGL: dose- res onse relationshi
C57BL/6J mice were infected for 3 days with varying doses
(PFU) of MCMV. The data in Table 30 show that the NK/LGL
response to MCMV was, in at least some parameters, biphasic.
Increasing the MCMV dose from 2 x 104 to 10 x 104 PFU led to
increasing numbers of total leukocytes and total LGL. However,
even the lowest virus dose tested (2 x 104 PFU) produced near-
maximal NK cell activity and LGL percentages. At high doses of
50 x 104 to 100 x 104 PFU, all measured response parameters began
to decline. As MCMV is known to be capable of inducing
immunosuppression in mice (Allan et al., 1982; Loh and Hudson,
1982), immunosuppression seems a likely explanation for the
reduced NK/LGL responses at the higher doses.
Table 30
Effect of MCM Dose on Liver NK/LGL Accumulation
Total
Virus Dose % YAC-1 Leukocytes Total LGL
sis Liver x10 x10PFUx10 % LGL Per Liver
None 3 . 1:t 0. :t 0. :t 0. :t 0.
30. :t 4. :t 0. 20. :t 2. 14. :t 2.
31. :t 5. 8 :t 3. 21. :t 2. 20. 
29. 14. :t 0. 13. 1.4 21. 
26. :t 9. 10. :t 2. 1.4 :t 3.
100 20. :t 6. 12. :t 0. :t 0. 1.2
C57BL/6J mice (n=2 per group) were uninfected i.p. with varying
- of MCM. Liver leukocytes were prepared at day 3 p. 
YAC-1 assays were run for 4 hr at E: T = 3: 1.
doses
CHAPTER VI
BLASTOGENESIS AN PROLIFERTION OF LGL IN TH LIVE
Data in the previous chapter demonstrate that high numbers
of LGL accumulate in the liver during the course of viral
infection. It has been recently shown (McIntyre et al., 1987)
that the accumulatien of total numbers of NK/LGL in the virus-
infected peritoneal cavity was severely reduced if mice were
irradiated prior to infection. This suggested that cell
proliferation was necessary for the accumulation of normal
numbers of LGL. The experiments presented below were conducted
to examine the potential contribution of blastogenesis and
proliferation of LGL to cell-mediated immune responses to viral
infection of the liver.
A. Effect of shieldin the bone marrow a ainst lethal irradiation
;;;
on NK/LGL res onse to MH infection
NK cell precursors are found predominantly in the bone
marrow (see Chapter I). The effects of protecting the bone
marrow environment from lethal irradiation on subsequent NK/LGL
responses to viral infection were examined. Table 31 shows that
shielding of the bone marrow resulted in NK/LGL responses that
were essentially no different from animals receiving total body
irradiation. The LGL percentage was actually significantly
higher (p (. 01) in leukocytes from total body-irradiated mice
Table 31
Effect of Shielding the Bone Marrow Against
Lethal Irradiation on the NK/LGL Response to MHV Infection
Irradiation
Treatment
% of
Leukocytes
% YAC-1 Total Leukocytes with LGL Total LGL
x 10 x 10sis holo
17 . :!4 . 1.8 :! 0. 11. :! 1.4 0 :! 0.
18. :!3 . 4 :! 0. 8 . O:! 0. 0 :! 0.
Total body
Bone marrow-
shielded
Mice (n=6 per group) received 900.R electron irradiation with or with-
out shielding of fore- and hindlims as described in Materials and
Methods. Mice were. then imediately infected with ME, and liver
leukocytes were obtained 3 days p. i 
byAC-1 assays were 4 hr at E:T = 10: 1.
than in leukocytes from bone marrow-shielded mice. This was
apparently due to higher percentages of polymorphonuclear
leukocytes (which "diluted out" the LGL) in the bone marrow-
shielded populations compared to total body-irradiated
populations (23% vs 9. 7%, respectively; p (. 02).
B. Role of the s leen in NK/LGL res onse to MH infection
Since the spleen is a site of mature NK cell blastogenesis
during viral infection (Biron and Welsh, 1982), it was
hypothesized that the spleen might be providing a significant
number of the LGL accumulating in the liver. The ability of the
spleen alone to provide NK/LGL for the early immune response was
examined. Mice were anesthetized and their spleens were isolated
outside the abdominal wall under lead shielding. Electron
irradiation (900 R) was then administered to these mice and to
similarly operated mice without lead-shielded spleens. The
shielded spleens contained 7-20-fold greater numbers of viable
leukocytes than did the irradiated spleens at day 3
postirradiation (data not shown). Table 32 indicates that, in
those animals whose spleens were spared from the irradiation,
NK/LGL responses in the liver to MH infection were not
significantly greater than in those animals whose spleens were
- irradiated. Preserving the proliferative capacity of splenic
NK/LGL did not alter the deleterious effects of lethal
irradiation of other lymphoid compartments. However, other
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effects of irradiation such as altered lymphocyte trafficking
patterns or the generation of factors inhibiting proliferation of
viable cells could have accounted for these results as well as
the results obtained in the bone marrow shielding experiments
above. Because of this uncertainty, a splenectomy model was used
to examine the contribution of NK/LGL made by the spleen. Mice
were splenectomized or sham-operated and then infected with MH.
At day 3 p. i., the absence of a spleen did not appreciably alter
the NK/LGL response in the liver (Table 33). Thus, by two
different methods, a significant role of the spleen in providing
NK/LGL to this non-lymphoid compartment could not be
demonstrated.
C. LGL with blast cell mor holo in freshl isolated liver
,1.
"'-
leukoc tes
Careful scrutiny of stained cytocentrifuge smears made from
virus-activated liver leukocyte populations revealed the presence
of considerably enlarged LGL with intensely basophilic cytoplasm
and often conspicuous nucleoli (Figure 4). This morphology was
consistent with that usually attributed to blast lymphocytes
(Hayry and von Willebrand, 1981). Occasionally, mitotic figures
were seen which contained prominent azurophilic cytoplasmic
granules (Figure 4). Since these leukocytes were freshly
isolated from the liver and not cultured in vitro, their presence
suggested that LGL in the liver were undergoing blastogenesis and
103
Table 33
NK/LGL Response to MH Infection in Splenectomized Mice
% of Leuko-
% YAC-1 cytes with Total LGL
Treatment sis LGL Mo holo x 10
Sham 27. :t 8. :t 1.3 6:t 1.7
Splenectomy 31. :t11. 0 :t 2. :t 2.
C57BL/6J mice were sham-operated or splenectomized as
described in Materials and Methods, and then imediately
infected with MH. Liver leukocytes were harested at
day 3 p. i.
YAC-1 assays were run for 4 hr at liver E: T = 17: 1.
Figure 4
104
Figure 4. LGL and blast LGL isolated from the livers of virus-
infected mice. A. Endogenous LGL. B. Blast LGL and endogenous
LGL. C. Mitotic figure with cytoplasmic granules (mitotic LGL).
Wright I S and Giemsa, X 400.
105
106
proliferation.
D. Size fractionation of blast LGL
Viral infection or exposure to IFN in vivo elicits the
blastogenesis of spleen NK cells with a concomitant increase in
cell size (Biron and Welsh, 1982; Biron et al., 1984). Upon size
separation by centrifugal elutriation, 3H-thymidine-
incorporating blast spleen cells are contained almost exclusively
within the large-cell fractions 4, 5, and 6 (Biron and Welsh,
1982) . Centrifugal elutriation was here employed to separate
poly I:C-stimulated liver leukocytes into populations of
increasing siz , and the number of leukocytes recovered in each
fraction was determined. Cytocentrifuge smears of each fraction
were analyzed by light microscopy for the proportion of LGL
exhibiting non-blast or blast cell morphology (as defined in
Chapter II). The total number of non-blast LGL and blast LGL in
each fraction was then calculated. Figure 5 shows that the
majority (81%) of he LGL exhibiting blast cell morphology were
recovered in the large cell fractions (fractions 4-6). The
small cell fractions (fractions 1-3) contained 61% of all non-
blast LGL recovered and had few LGL that were blast LGL. Thus,
these data show that morphological criteria could be used to
classify LGL into blast and non-blast populations and that poly
I:C elicited LGL with blast size and morphology in the liver.
co CD 
X) NOI VI::l/S"
107
(I a:
...
Figure 5. Size separation of blast LGL by centrifugal
elutriation. Leukocytes from the livers of poly I:C-treated mice
were separated into fractions of increasing cell size (fractions
1 through 6, respectively) by centrifugal elutriation as
described in Materials and Methods. The total numer of
leukocytes in each fraction was determined. The percentage of
leukocytes in each fraction exhibiting non-blast LGL morphology
and blast cell/mitotic figure LGL morphology was assessed by
differential counts of Wright' -Giemsa stained cytocentrifuge
smears. The total numer of non-blast LGL (OPEN BARS) and blast
LGL (SOLID BARS) recovered in each fraction was then calculated.
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E. Association of blast LGL with au ented NK cell activit
As shown in Table 34, increases in NK cell activity (YAC-1
cell lysis) and in the number of LGL in livers following 
infection were associated with increases in the proportion of
those LGL exhibiting a blast cell morphology. LGL in the liver
at this time (day 3 p. ) have been previously well-characterized
as NK cells on the basis of cell surface phenotype and lytic
profile (see Chapter V). Treatment of mice with anti-asialo GMI
serum, which selectively depletes NK cell activity in vivo (Habu
et al., 1981), abrogated the majority of the virus-induced
increases in blast LGL as well as non-blast LGL (Table 34).
These data suggest that the blast LGL were NK cells.
F. Th idine-incor oratin killer cells in the liver
The presence of morphologically-defined blast LGL in leuko-
cyte populations freshly isolated from the liver during viral
infection suggested that cytotoxic lymphocytes were proliferating
at this site. To confirm that the specific cells mediating the
killing were indeed blast cells, non-adherent leukocytes from
livers of control mice and MH-infected mice at day 3 p. i. were
labeled with 3H-thymidine and tested in single cell cytotoxicity
assays with autoradiography. The data in Table 35 show that 
induced significant increases in NK cell-mediated lysis and in
the percentage of LGL with blast cell morphology. Leukocytes
from infected mice which had bound a target were more lytically
109
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active (% killing in conjugates) compared to cells from control
mice. Most importantly, a significantly (p (. 001) greater
percentage of the lytic activity was mediated by 3H-thymidine-
incorporating effector cells (% killing mediated by blast cells)
from infected mice than from uninfected mice. Thus, compared to
un infected control leUkocytes, day 3 p. i. leukocyte populations
from the liver incorporated more 3H-thymidine, had higher
proportions of LGL demonstrating blast cell morphology, and had
significantly increased numbers of 3H-thymidine-incorporating
leukocytes that bound to and lysed NK cell-sensitive targets.
These data show that leukocytes freshly isolated from this non-
lymphoid compartment at day 3 p. i. contain 3H-thymidine-
incorporating, functionally active, blast NK cells.
G. Blast NK/LGL are induced b several virus infections
The presence of blast NK/LGL in the leukocytes isolated. from
liver was examined in several mouse strains infected with
different viruses. Viral infection resulted in significant
increases in both the percentages and total numbers of blast
NK/LGL at day 3 p. i. (Table 36). The liver-derived blast (and
non-blast) NK/LGL at day 3 p. i. were significantly depleted (p (
05) by in vivo treatment with anti-asialo GMI serum.
immunodeficient strains of mice were also examined for the induc-
tion of blast NK/LGL in the liver. T cell-deficient nude 
mice generated large numbers of blast NK/LGL in response to LCMV
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infection as well as to treatment with the interferon-inducer
poly I:C (Table 36), suggesting a major role for interferon in
the blastogenesis of NK/LGL in the liver. Beige ( ) mutant
mice, which are deficient in NK cell activity (Roder and Duwe,
1979), nevertheless responded to MH infection with vigorous LGL
blastogenesis (Table 36). The majority (81. t 2. 1 %) of the
blast NK/LGL at day 3 p. i., however, had abnormal granule
morphology, i. e., one to three large granules, typical of beige
NK/LGL (Itoh et al., 1982).
H. Kinetics of LGL blasto enesis
The kinetics of LGL blastogenesis in the peritoneal cavity
has been examined during MH infection (McIntyre et aI, 1987),
where both the percent of the LGL that were blasts and the total
numbers of blast LGL in the peritoneal cavity peaked at day 3
p. i. and then declined rapidly. By day 7 p. i. with MH, LGL
blastogenesis and total LGL number had returned to control values
(McIntyre et aI, 1987).
The kinetics of LGL blastogenesis in the liver was examined
following infection of C3H/St mice with the hepatotropic WE
strain of LCMV (LCMV-WE) or the non-hepatotropic Armstrong strain
of LCMV (LCMV-AR). lricreases in blast LGL proportion were
evident as early as day 1 p. i. with both viruses (Figure 6), but,
in contrast to MH-induced blastogenesis (McIntyre et al., 1987),
LCMV-induced blastogenesis remained elevated through day 7 p.
1I-
if.
ijc
=",...;:' , " " " " " " " " -
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Figure 6. Kinetics of LGL blastogenesis during LCM infection.
Mice (n=2-4 per group) were infected with LCM-AR (0 '
.) 
LCM-WE (0 
.) 
and liver leukocytes were prepared at the
indicated times postinfection. Percent of the LGL exhibiting
Numer of blast LGL (x 10 ) perblast morphology 
) .
liver (. 
- - - - - - - 
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before declining. This was a difference between LCMV and MH,
not of liver and peritoneal cavity, as the peritoneal blast LGL
response to LCMV-AR resembles that of the liver (Biron et al.,
1986; Dr. R. Natuk, personnel communication). Compared to
infection with LCMV-AR, infection with LCMV-WE resulted in
significantly (p (. 02) higher percentages of blast LGL in liver
leukocytes by day 3 p. i., and this difference persisted through
day 14 p. i. The total number of blast LGL in livers infected
with either LCMV-AR or LCMV-WE peaked at day 7 p. i., but these
levels were 13-fold higher following hepatotropic LCMV-WE
infection.
I. Resistance to anti-asialo GM1 seru of i. blast LGL
In the spleen during LCMV infection, NK cells undergo peak
blastogenesis at day 3 p. i. (Biron and Welsh, 1982) and CTL
undergo peak blastogenesis at day 7 p. i. (Biron et al., 1986).
The prolonged LGL blastogenesis in the liver during LCMV
infection (Figure 6) suggested that a portion of the blast LGL
present, especially later in infection, could be of the CTL
phenotype. Since blast NK/LGL at day 3 p. i. were sensitive to
depletion by in vivo treatment with anti-asialo GMI serum (Tables
34 and 36), the sensitivity of blast LGL at day 7 post-LCMV
infection to depletion by anti-asialo GMI was tested.
contrast to the findings at day 3 p. i., two treatments with anti-
as ialo GM 1 serum in vivo did not reduce day 7 - p. i. LGL
blastogenesis in C57BL/6J mice infected with LCMV-AR or 
C3H/St mice infected with LCMV-WE (Table 37). These treatments
significantly depleted NK cell activity (YAC-l lysis) but not
LCMV-specific CTL activity.
J. L t-2 henot e of blast LGL
The blast LGL populations from the livers of mice at days 3
and 7 p. i. with LCMV were examined by FACS for expression of the
CTL-specific marker Lyt-2. At day 3 p. i., the majority of the
LGL (77%), blast LGL (81%) and NK cell activity was found in Lyt-
2- FACS-sorted populations from the liver (Table 38).
contrast, most LGL (58%) and blast LGL (82%) in the liver at day
7 p. i. were Lyt - 2+ . NK cell activity at day 7 p. i. was still
mediated by Lyt-2- cells. Lyt-2+ cells, which were devoid of CTL
activity at day 3 p. i., expressed high levels of virus-specific
(CTL) lysis at day 7 p. i. (Table 38). These data indicate that
LGL blastogenesis shifted from NK cell-rich, Lyt-2- leukocytes at
day 3 p. i. to CTL-rich, Lyt-2+ leukocytes at day 7 p. Even
though Lyt-2- LGL, presumed to be NK cells, were still present at
day 7 p. i., few of them were dividing.
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CHAPTER VII
DISCUSSION
The data in this thesis demonstrate morphologically,
phenotypically, and functionally the accumulation of cytotoxic
effector lymphocytes in the liver during viral hepatitis.
Adoptive transfer experiments show that spleen cell populations
containing virus-specific CTL most likely mediate their antiviral
effects in vivo by a mechanism of direct cytolysis. Thus, the
correlation of in vivo antiviral cytotoxic function with the in
situ accumlation of cells displaying a cytotoxic morphology
(LGL) strengthens the proposals that reductions in infectious
virus titers and that tissue pathology in certain viral diseases
are cytotoxic cell-mediated immune phenomena.
ulation of LCMV infection b totoxic lymphoc tes
A growing body of evidence (Welsh and Kiessling, 1980;
Buk9wski et al., 1983b; Bukowski et al., 1984; Bukowski et al.,
1985) has indicated, either directly or indirectly, that NK cells
play no apparent role in resistance to LCMV infection. Similar
conclusions have been drawn from studies with Sindbis virus
(Hirsch, 1981). The findings in the LC system were confirmed
and extended here to show that acute infection with the strongly
hepatotropic LCMV-WE st ain resulted in equivalent levels of
mm.
T1,
;1!'
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viral replication in the presence or absence of NK cells (Table
1) . This suggested that the very limited replication of LCMV-AR
in certain organs (such as the liver) during acute infection was
not responsible for its resistance to NK cell-mediated antiviral
effects. A more likely explanation for this resistance was that
the IFN generated during the early course of LCMV infection
(Welsh, 1978a) protected LCMV-infected target cells in vivo from
activated NK cell-mediated lysis (Bukowski and Welsh, 1985b).
Additionally, NK cell depletion by anti-asialo GMI treatment of
mice persistently infected with LCMV-AR (which grows to high
titer in many organs, including the liver) did not affect virus
synthesis (Table 2), confirming earlier studies by Bukowski et al
(1983a). However, since persistently infected mice make an
antibody response to LCMV (Oldstone and Dixon, 1967). the
presence of anti-LCMV antibody in these mice may have greatly
overshadowed, in the short term of the observation period, a
minor contribution of NK cells to the control of the persistent
infection.
Although a direct anti-LCMV effect of NK cells could not be
shown, the possibility of NK cells exerting an antiviral function
via ADCC in LCMV infection was examined. NK cells express on
their surface receptors for the Fc portion of immunoglobulin
(Herberman et al., 1977), and consequently are capable of
mediating ADCC (Ojo and Wigzell, 1978; Bradley and Bonavida,
1982) . ADCC has been suggested as a mechanism of antiviral
esistance in passively immunized, Sindbis virus-infected mice
(Hirsch et al., 1979). A role for NK cell-mediated ADCC was
tested by passively immunizing naive mice with anti-LCMV antibody
then infecting them with LCMV in the presence or absence (anti-
asialo GMl-treatment) of NK cells. By this technique, an
antibody-dependent, NK cell-mediated antiviral activity could not
be demonstrated (Table 4). Use of the less specific
immnosuppressant cyclophosphamide (CY) in a similar passive
(antibody) protection protocol again did not reveal an antibody-
cellular immune system interaction (Table 5). Interestingly,
mice treated with CY alone had lower titers of LCMV than infected
control mice (Table 6). This suggested that the CY treatment may
have depleted a cell population that would otherwise have
supported viral replication.
A portion of the antiviral effect of immune serum transfer
did, however, appear to involve components of the C system, as
cobra venom factor (CVF)-treated, passively immunized mice had
higher virus titers than mice receiving anti-LCMV antibody alone
(Table 6). The C system has been implicated as playing a
significant role in antibody-mediated protection (Hirsch et al.,
1978; Schmaljohn et al., 1982) as well as in antibody-mediated
tissue damage (Oldstone and Dixon, 1971) during acute viral
infection. Complement-mediated, antibody-dependent lysis of
virions and/or LCMV-infected cells is likely responsible for the
results obtained here.
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Mice acutely infected .with LCMV receiving virus-immune
spleen cells at early stages of infection rapidly clear virus in
the spleen and other organs (Zinkernagel and Welsh, 1976).
Adoptive immunization of mice infected with LCMV required theta-
bearing lymphocytes from LCMV-immne mice syngeneic with
recipient mice in the K or D, but not I, regions of the H-2 locus
of the major histocompatibility complex (MHC) (Zinkernagel and
Welsh, 1976). Since CTL have similar K/D recognition patterns,
it was suggested that the adoptive immunization may be mediated
by CTL which lyse the virus-infected target cells in vivo (see
Chapter I). Byrne and Oldstone (1984) have recently shown that
LCMV- specific cloned CTL can also mediate adoptive immunization.
However, upon recognition of an appropriate target, T cells
secrete a number of soluble factors including immune (gama) IFN
(Morris et al., 1982), macrophage migration inhibition factor
(Newman et al., 1978), and lymphotoxins (Hiserodt et al., 1979).
Gama IFN has been shown to markedly inhibit virus synthesis
(Wheelock, 1965), to activate NK cells (Kumar et al., 1979), and
to activate macrophages (Schultz and Chirigos, 1979). All these
factors could contribute to the resistance to various virus
infections. It is possible, therefore, that the antiviral effect
seen during adoptive immunization is not due to direct and
specific cytotoxicity, but to nonspecific events that follow
triggering of the T cell by antigen recognition.
Previous studies had shown that vaccinia virus-immune
splenocytes failed to immunize against LCMV infection, but they
were transferred into mice only infected with LCMV and were
unlikely to be stimulated in that environment (Zinkernagel and
Welsh, 1976). The experiments described here, however, were
designed to ensure that the transferred immune T cells were
reactive with antigens in the recipient mice. Alloimmune CTL
transferred into LCMV-in ected recipients expressing the foreign
MHC antigens to which the immune cells had been primed exerted no
demonstrable antiviral effect (Table 8). However, in vivo
activity of these cells was not documented.
The experiments utilizing dually infected recipient mice
provided more conclusive results. Using a dual infection model
with totally unrelated viruses (LCMV and vaccinia virus),
significant reductions in the titers of only the virus which
sensitized the transferred spleen cells were noted, with no
significant effect on the titers of the "bystander" heterologous
virus (Table 12).
Pichinde virus (PV) was substituted for vaccinia virus in
later studies of adoptive immunization of .dually infected mice.
As PV is an arenavirus closely related to, but antigenically
distinct from, LCMV (Buchmeier et al., 1981), this combination
would require a high degree of specificity on the part of the
adoptively transferred immune cells to mediate a selective
reduction in titer of only one of the two viruses. As shown in
Table 16, reduction of titers in mice infected with only one
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virus was, as suspected, mediated only by the relevant virus-
immune splenocytes. In mice dually infected with LCMV and PV,
LCMV titers were reduced upon transfer of LCMV-immune
splenocytes, and PV titers were reduced by PV-immune splenocytes;
in neither instance was a significant reduction in the titer of
the heterologous virus observed (Tables 16 and 17).
This exquisite specificity in adoptive immunization was
somewhat surprjsing. One might expect that virus in the vicinity
of other viruses to which the immune response is directed may be
affected by non-specific lymphokines. However, only H - 2K or H - 2D
compatibility is required for adoptive immunization in tha LCMV
system (Zinkernagel and Welsh, 1976), and an LCMV-specific, H-2-
restricted CTL clone can successfully transfer adoptive immunity
in LCMV-infected histocompatible mice (Byrne and Oldstone, 1984).
This indicates that cells with cytotoxic T cell phenotypes and
recognition patterns mediate antiviral effects in vivo, but still
do not discrimina e between direct in vivo cytotoxic effects and
potential non-specific antiviral effects mediated by soluble
factors.
A report by Lukacher et al (1984) has demonstrated specific
virus reduction in the lungs of dually infected mice following
adoptive transfer of anti-influenza virus CTL clones: In mice
infected with two influenza A subtypes, a subtype-specific clone
reduced virus titers only of the recognized subtype. A subtype
cross-reactive clone lowered titers of both subtypes. The in
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vivo reactivity of these clones mirrored their in vitro cytolytic
reactivities. This work, like the present studies, is consistent
wi th a highly localized effect of the T ce ls, such as direct
cytotoxici ty. However, prior success in the influenza virus CTL
clone adoptive transfer model has been highly variable, with some
clones providing in vivo protection (Lin and Askonas, 1981) while
others do not (Taylor and Askonas, 1983), despite showing in
vitro cytolytic specificity. Therefore, the inhibition of virus
replication seen in the adoptive transfer models using cloned CTL
lines may represent specificity phenomena peculiar to the
individual clones used. The present data, obtained following
adoptive transfer of immune whole spleen cells, may more closely
reflect the normal antiviral activity of the specific immune
response of the infected host.
Thus, two classes of potent cytotoxic effectors, NK cells
and CTL, are generated during LCMV infection. Despite the
conclusively demonstrated role of NK cells in providing
protection against infection with certain other viruses (Bukowski
et al., 1985), no such role for NK cell-mediated antiviral
resistance has been shown in LCMV infection. This pertains to NK
cell natural cytotoxicity as well as to NK cell-mediated ADCC in
both acute and persistent LCMV infections. However, the results
demonstrating an exquisite specificity in virus reduction by
transferred immune cells strongly support the concept that T
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cell-dependent adoptive immunization against arenavirus
infections involves direct in vivo cytotoxic effects by the
virus-immune splenocytes. A highly restricted and extremely
localized, but virus-non-specific, antiviral effect following
antigen recognition by the immune splenocytes is another
possible, but less likely, explanation for the data.
Cell-mediated imunit in viral he atitis
These data demonstrate for the first time the accumulation
of both NK/LGL and CTL/LGL in the liver during a virus infection.
The accumulation of these cells correlates with the appearance of
NK cell and CTL cytotoxic activities. During the early course of
infection, cytopathic viruses induce more extensive NK/LGL
responses in the liver than do non-cytopathic viruses. Infection
with the hepatotropic LCMV-WE strain results in 'a significantly
greater CTL/LGL response in the liver on day 7 p. i. than does
infection with the non-hepatotropic LCMV-AR strain. Zinkernagel
et al (1986) have recently presented similar results confirming
the ability of LCMV-WE infection (compared to LCMV-AR infection)
to induce higher levels of CTL activity and total numbers of
inflamatory cells in the livers of mice, correlating with more
extensive clinical disease.
The NK cell activity in the liver is similar to the NK cell
activity reported in the spleen during LCMV infection (Welsh,
1978a) . The phenotype of the liver-derived NK cell is asialo
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GMI + , Thy 1.
+/ -
, and Jlld- , and the cell is contained within a
population of leukocytes bearing the LGL morphology (Table 20).
Liver NK/LGL activated in vivo by poly I:C treatment could be
enriched in plastic non-adherent cell populations (Table 23).
The early appearance (day 1-2 p. i. ) of augmented NK cell lytic
activity in the liver is also se n in the spleen (Welsh, 1978a)
where activity peaks around day 3 p. i. and then declines.
Furthermore, the liver leukocytes contain "activated" NK cells at
day 3 p. i. as evidenced by their ability to lyse L-929 cells, a
target resistant to "endogenous" NK cell-mediated lysis (Figure
2D) . The lysis of NK cell-sensitive YAC-l cells by liver
leukocytes continues to remain above endogenous levels on day 7
p. i. with LCMV-AR (Figure 2E), but lysis of the more resistant
L929 cells is declining (Figure 2D). This prolonged elevation of
NK cell-mediated lysis against YAC-1 cells has also been observed
in peripheral blood (Stitz et l., 1985). The circulating NK
cells at day 7 p. i. are lytically active against YAC-l targets
but they have lost their ability to lyse the more resistant L-929
cells (Stitz et al., 1985). Thus, the high NK cell-mediated
lysis against YAC-l cells seen in the liver and blood at day 7
p. i. is more likely due to the high NK cell number rather than to
an activated state of the NK cell population. This may reflect
the fact that IFN levels, required for NK cell activation,
decline after 3 days post infection (Welsh, 1978a).
The. early cellular (NK/LGL) immune responses in the liver
following non-hepatotropic LCMV-AR and hepatotropic LCMV-WE
infections are quite similar, with NK cell activities and LGL
numbers being relatively parallel for the two infections through
day 5 p. i. (Figure 2). This may indicate that the augmentation
of NK cell activity and LGL number in the liver is due to
systemic effects of IFN rather than to virus replication in the
liver. The IFN- inducer poly I: C stimulat s comparable increases
in NK cell acti vi ty and LGL number (Table 27). In contrast, 
and MCMV, which cause highly cytopathic infections of
hepatocytes, stimulate much higher levels of NK/LGL in the liver
(Table 27). This is also apparent in beige mutant mice which,
despite having defective NK cell function (Roder and Duwe, 1977),
respond to cytopathic MH infection with large numbers of
abnormal NK/LGL. In these circumstances, the presence of the
virus, by virtue of its lysing target cells, may provide an
important stimulus for NK cell accumulation as virus-infected
cells have been shown to release factors which are chemotactic
for leukocytes (Ward et al., 1972).
Bukowski et al (1985) demonstrated that NK cells playa role
in the early resistance to MCMV infection, and suggested that NK
cells may provide resistance agaiRst. MH infection as well
(Bukowski et al., 1983b). In contrast, LCMV infection does not
seem to be regulated by NK cells (Bukowski et al., 1985; Bukowski
et al., 1983a, b; and present results). The tendency of a
particular virus infection to attract a significant number of
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NK/LGL to a site of virus replication may be one factor in
determining its sensitivity to NK cell-mediated anti-viral
resistance.
Several lines of evidence support the notion that the CTL
lytic activity of liver leukocytes is being mediated by cells
with an LGL morphology: 1) the CTL activity and the LGL present
in the liver on day 7 p. i. are mostly resistant to in vivo
treatment with anti-asialo GMl' a treatment which depletes NK/LGL
(Table 24) 2) leukocytes isolated from livers at day 7 p.
with LGL morphology and CTL activity are at leas partially
sensitive to in vitro treatments with anti-Thy 1. 2 + C and
anti-Lyt-2 + C (Table 20) 3) CTL activity and LGL at day 7 p. i.
are enriched in FACS-sorted Lyt-2+ leukocytes (Table 21), and 4)
the levels of CTL activity and numbers of LGL are very closely
correlated on days 7-14 p. i. (Figure 2). Thus, this suggests
that virus-specific CTL in the liver at day 7 p. i. are LGL, and
that the activity and number of these cells are directly related
to the extent of virus replication that has occurred in this
organ. The recent demonstrations that virus-specific CTL
generated in the spleen acquire LGL morphology (Biron et al.,
1986) and that adoptive transfer of virus-specific CTL can damage
LCMV-infected hepatocytes in vivo (Zinkernagel et al., 1986)
further support this claim.
The basis for the large inflamatory cell response in the
livers of mice infected with hepatotropic LCMV-WE was likely to
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be due either to an enhanced nonspecific inflamatory cell
response whic , by chance, included a proportion of CTL/LGL, or
to virus-specific T cells homing to the LCMV-WE-infected liver
and generating signals which attracted other inflamatory cells
into the organ. The lack of a large LCMV-WE-induced inflamatory
cell infiltrate in mice at 3 days postinfection (Figure 2) or in
mice at 7 days p. i. (Table 26) suggests that the T cell
hypothesis may be correct. Supporting this hypothesis is that
inflamatory responses in the brain or footpad of LCMV-infected
mice are dependent upon the presence of H-2K- or D-restricted T
cells (Doherty et al., 1976; Zinkernagel, 1976). The fact that a
higher inflamatory response in the liver was seen with LCMV-WE
than with LCMV-AR is probably due to the fact that LCMV-WE
replicates to higher titers ()100-fold) in the liver. LCMV - 
infection did not appear to prevent accumulation of leukocytes in
the liver, as mice co-infected with both LCMV-AR and LCMV-WE
accumulated numbers of liver leukocytes and LGL higher than mice
infected with LCMV-AR alone and these numbers were not
significantly different than mice infected only with LCMV-WE
(data not shown).
The majority of experimentation in murine viral immunology
has relied on findings obtained predominantly from spleen cells.
The data presented in Table 25 demonstrate that, under certain
circumstances, cytotoxic activity mediated by .spleen cells may
not accurately reflect ongoing immune responses elsewhere in the
1.3
body. The basis for the markedly reduced spleen CTL response in
C57BL/6J mice infected with LCMV-WE (compared to LCMV-AR-
infected mice) is not known. Two possibilities are that there is
a defect in the spleen for the generation of LCMV-specific CTL
under these conditions of LCMV infection, or else the liver may
serve as a stimulus to rapidly recruit CTL out of the spleen.
These findings underscore the importance of examining other
compartments of the virus-infected host for signs of a localized
immune response, especially if the virus exhibits specific tissue
tropism(s) .
Thus, it has been shown that during virus infection two
waves of LGL influx occur in the liver, and they are associated
with the histopathological features of viral hepatitis. The
first of these is a thymus-independent population of NK/LGL which
is significantly larger in cytopathic virus infections than in
non-cytopathic virus infections. The second wave of LGL is a
thymus-dependent influx occurring la during infection and
containing Lyt 2+ CTL/LGL. Significantly greater numbers of
CTL/LGL accumulate in the liver during an hepatotropic virus
infection than during a non-hepatotropic virus infection.
Blasto enesis of LGL in the liver durin viral infection
These studies document that the liver-associated increases
in NK/LGL and CTL/LGL seen at early and late stages of viral
infections, respectively, are associated with high levels of
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blastogenesis within these populations. This contrasts with
granulocyte responses, which are associated with accumulation of
non-dividing, end-stage cells in pathological lesions. At one
time NK cells were thought to be end-stage cells because of their
relative resistance to irradiation (Kiessling et al., 1977;
Hochman et al., 1978). This resistance, however, was a property
of endogenous, unstimulated NK cells, few of which are blasts
(Biron and Welsh, 1982). After IFN stimulation brought about by
viral infection, the NK cell population converts to a rapidly
dividing, blast cell-enriched population (Biron and Welsh, 1982;
Biron et al., 1984). Other studies showed that lethal total body
irradiation greatly reduces the NK/LGL infiltrate in the organs
of virus-infected mice (McIntyre et al., 1987), confirming that
cell division is required for the accumulation of these cells.
The kinetics of the NK/LGL blast response in the liver is
similar to that of the spleen and parallels that of the IFN
response. By mechanisms still unclear, IFN induces the
blastogenesis and proliferation of NK cells in vivo (Biron et
al., 1984). At late stages of the LCMV infection, a significant
number of the Lyt-2- LGL population mediating NK cell activity
can still be found in the liver (Table 38). However, the IFN
response at that time is low, and a very low percentage of the
Lyt-2- LGL have blast morphology. At this time there,
nevertheless, are high levels of blastogenes is wi thin the CTL
(Lyt-2+ LGL) component (Table 38).
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The presence of large numbers of blast NK/LGL and blast
CTL/LGL in virus-infected livers raises the question as to their
origin. Cell division could be taking place in these organs,
and/or cells with blast morphology could be preferentially
attracted to or trapped within this compartment. Data presented
indicate that a significant proportion of NK cells in the virus-
infected liver are 3H-thymidine-incorporating effector cells
(Table 35). This suggests that NK cells are, in fact, capable of
at least one round of proliferation in non-lymphoid organs but
does not rule out the possibility that many of the blast LGL may
have recently migrated into the virus-infected organs from other
compartments. Adoptive transfer experiments indicate that
antigen-sensitized blast lymphocytes migrate into sites of
inflamation more readily than do small lymphocytes (Asherson et
..-
al., 1973; Moore and Hall, 1973; McGregor and Logie, 1974). This
preferential accumulation is apparently not antigen-specific
(Asherson et al., 1973; Moore and Hall, 1973; McGregor and Logie,
1974), and may be at least partially explained by the blast
cells ' greatly increased motility (Hoffman et al., 1981).
Furthermore, localized production of IFN may enhance the
accumulation of migrating lymphocytes at sites of inflamtion
(Duijvestijn et al., 1986; Issekutz et al., 1986). Regardless, a
preferential accumulation of the responding blast lymphocytes
that generated in vivo during a developing immune response
may provide a means for the selective concentration of both non-
.--;..;\
136
;7.
specific (NK/LGL) and antigen-specific (CTL/LGL) blast effector
cells at the sites of antigenic stimulation.
It was hypothesized that the spleen would be a prominent
source of NK/LGL for peripheral target organs, since mature NK
cell blastogenesis and proliferation in the spleen increase
dramatically during infection, while the lymph nodes, peripheral
blood, and bone marrow contain very few functional proliferating
NK cells (Biron and Welsh, 1982; Biron et al., 1984 Welsh et
al., 1984a). However, neither splenectomy (Table 33) nor
shielding the spleen (Table 32) or bone marrow (Table 31) during
irradiation yielded any evidence implicating these sources as the
major contributor of NK/LGL response in the liver. It is
interesting to speculate that the liver itself may provide NK/LGL
from its pre-formed pool of effector cells for NK/LGL responses
elsewhere in the body.
CTL precursors proliferate in vivo in response to viral
(Biron et al., 1986; Allen and Doherty, 1985) and allogeneic
(Denizot et al., 1986) antigens, and they can differentiate into
cytolytic cells at a site of localized antigenic stimulation
(Ascher et al., 1981). At day 3 p. i. with LCMV the liver has few
Lyt-2+ cells, and they exhibit no virus-specific lytic activity
(Table 38). By day 7 p. i., the proportion of Lyt -2+ cells
increases dramatically in this compartment and high percentages
of the Lyt-2+ LGL display blast cell morphology. The presence of
these Lyt-2+ blast LGL strongly suggests that CTL are also
137
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capable of at least limited proliferation in this organ.
i:. The kinetics of the LGL response varied with the viruses
tested. Hepatotropic LCMV-WE infection induced the blastogenesis
of a significantly greater proportion of the LGL in the liver
than does non-hepatotropic LCMV-AR infection. The extens i ve
replication of LCMV-WE in the liver (Table 1; Welsh, 1984b)
apparently serves as a strong stimulus for local LGL
blastogenesis, which likely contributes to the greater numbers of
total LGL (Figure 2) and blast LGL (Figure 6) at day 7 p. i. 
compared to LCMV-AR infection. In contrast, a virus-specific
CTL response to MH infection has not been described (Wege et
al., 1982), and MH does not induce the accumulation of large
numbers of LGL in infected organs at day 7 p. i. (Natuk and Welsh,
1987). These observations are supported by a lack of LGL
blastogenesis late in MH infection (McIntyre et al., 1987) when
CTL would otherwise be expected to be undergoing proliferation.
These data have demonstrated that dividing NK cells are
present in livers of virus-infected mice. Increases in NK/LGL
number are sensitive to irradiation and are strongly associated
wi th increased proportions of LGL with blast cell morphology and
with killing mediated by 3H-thymidine incorporating lymphocytes.
In viral infections (such as LCMV) which induce a potent CTL
response, CTL/LGL blastogenesis also occurs in the liver, peaking
later in infection. The blastogenesis and proliferation of
cytotoxic effector cells at localized sites of viral replication
may provide a mechanism for in situ amplification of crucial
components of the host' s anti -viral defenses.
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